Abstract

Cannabis sativa is an annual herb of the MORACEAE family that grows to 5 m tall. It is usually erect; stems variable, with resinous pubescence, angular, sometimes hollow, especially above the first pairs of true leaves; basal leaves opposite, the upper leaves alternate, stipulate, long petiolate, palmate, with 3–11, rarely single, lanceolate, serrate, acuminate leaflets up to 10 cm long, 1.5 cm broad. Flowers are monoecious or dioecious, the male in axillary and terminal panicles, apetalous, with five yellowish petals and five poricidal stamens; the female flowers germinate in the axils and terminally, with one single-ovulate ovary. Fruit is brown, shining achene, variously marked or plain, tightly embraces the seed with its fleshy endosperm and curved embryo; late summer to early fall; year-round in tropics.

Keywords

Tourette Syndrome Fatty Acid Amide Hydrolase Cannabis User Petroleum Ether Extract Transient Global Amnesia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. CS001.
    Crombie, L., W. M. L. Crombie and S. V. Jamieson. Isolation of cannabispirsdienone and cannabidihydrophe-nanthrene. Biosynthetic relationships between the spirans and dihydrostibenes of Thailand. Tetrahedron Lett 1979; 1979:661.Google Scholar
  2. CS002.
    Ahmad, Y. S. A Note on the Plants of Medicinal Value Found in Pakistan. Government of Pakistan Press, Karachi, 1957.Google Scholar
  3. CS003.
    Bose, B. C., A. Q. Saifi and A. W. Bhagwat. Studies on pharmacological actions of Cannabis indica. Part III. Arch Int Pharmacodyn Ther 1964; 147:291.PubMedGoogle Scholar
  4. CS004.
    Shoyama, Y., T. Yamauchi and I. Nishioka. Cannabis. V. Cannabigerolic acid monomethyl ether and cannabinolic acid. Chem Pharm Bull 1970; 18: 1327–1332.Google Scholar
  5. CS005.
    Rousinov, K. S. and S. Athanasova-Shopova. Experimental screening of the anticonvulsive activity of certain plants used in popular medicine in Bulgaria. C R Acad Bulg Sci 1966; 19: 333–336.Google Scholar
  6. CS006.
    Krejci, Z., M. Horak and F. Santavy. Constitution of the cannabidiolic acid, M.P.133, isolated from Cannabis sativa. Acta Univ Palacki Olomuc Fac Med 1958; 16:9.Google Scholar
  7. CS007.
    Dhar, M. L., M. M. Dhar, B. N. Mehrotra, and C. Ray. Screening of Indian plants for biological activity. Part I. Indian J Exp Biol. 1968; 6: 232–247.PubMedGoogle Scholar
  8. CS008.
    Barros, G. S. G., F. J. A. Mathos, J. E. V. Vieira, M. P. Sousa and M. C. Medeiros. Pharmacological screening of some Brazilian plants. J Pharm Pharmacol 1970; 22: 116.PubMedGoogle Scholar
  9. CS009.
    Segelman, A. B., F. H. Pettler and N. R. Farnsworth. Cannabis sativa (marihuana). A correction of reported thin-layer chromatography data. Pharm Wkly 1970; 105: 1360–1362.Google Scholar
  10. CS010.
    Saha, J. C., E. C. Savini and S. Kasinathan. Ecbolic properties of Indian medicinal plants. Part 1. Indian J Med Res 1961; 49: 130–151.Google Scholar
  11. CS011.
    Berhault, J. Flore Illustree du Senegal II. Govt. Senegal, Min Rural Dev, Water and Forest Div. Dakar 1974; 2.Google Scholar
  12. CS012.
    Dixit, V. P. and N. K. Lohiya. Effects of cannabis extract on the response of accessory sex organs of adult male mice to testosterone. Indian J Physiol Pharmacol 1975; 19: 98–100.PubMedGoogle Scholar
  13. CS013.
    Perrot, E. and P. Hurrier. Matiere Medicale Et Pharmacopee Sino-Annamites. Vigot Freres, Edit. Paris, 1907; 292 pp.Google Scholar
  14. CS014.
    Soubeiran, J. L. and M. D. Thiersant. La Matiere Medicale Chez les Chinois. G. Masson, Paris. 1874.Google Scholar
  15. CS015.
    Anon. Lilly’s Handbook of Pharmacy and Therapeutics. 5th Rev, Eli Lilly and Co., Indianapolis, IN, 1898.Google Scholar
  16. CS016.
    Chakravarty, I. and J. J. Ghosh. Cannabis and the oestrous cycle of adult rats. U N Document St/Soa/Ser S/38 1973; 38.Google Scholar
  17. CS017.
    De Zeeuw, R. A., T. B. Vree and D. D. Breimer. Cannabivarichromene, a new cannabinoid with a propyl side chain in Cannabis. Experientia 1973; 29: 260.PubMedGoogle Scholar
  18. CS018.
    Bercht, C. A. L., R. J. J. C. Lousberg, F. J. F. M. Kuppers, C. A. Salemink, T. B. Vree, and J. M. van Rossum. Cannabis: VIII. Identification of cannabinol methyl ether from hashish. J Chromatogr 1973; 81: 163.PubMedGoogle Scholar
  19. CS019.
    Korte, F., M. Haag and U. Claussen. Tetrahydrocannabinol carboxylic acid, a component of hashish. Angew Chem Int Ed Engl 1965; 4: 872.PubMedGoogle Scholar
  20. CS020.
    Van Ginneken, C. A. M., T. B. Vree, D. D. Breimer, H. W. H. Thijssen and J. M. van Rossum. Cannabinodiol, a new hashish constituent, identified by gas chromatography-mass spectrometry. Proc Int Symp Gas Chromatogr Mass Spectrom 1972; 1972: 109.Google Scholar
  21. CS021.
    Min, P. The drugs employed in Chinese medicine as antidiabetica. III. Experimental investigation on the influence of the drugs employed in Chinese medicine as antidiabetica on the blood sugar of rabbits. Nippon Yakurigaku Zasshi 1930; 11(2): 181–187.Google Scholar
  22. CS022.
    Carlini, E. A. and R. J. Gagliardi. Comparison of the pharmacological actions of crude extracts of Olmedioperebia calophyllum and Cannabis sativa. Ancad Bras Cienc 1970; 42: 409–412.Google Scholar
  23. CS023.
    Papadakis, D. P., C. M. Michael, T. A. Kephalas and C. J. Miras. Effects of cannabis smoking in blood lactic acid and glucose in humans. Experientia 1974; 30(10): 1183–1184.PubMedGoogle Scholar
  24. CS024.
    Podolsky, S., C. G. Pattavina and M. A. Amaral. Effect of marijuana in the glucose-tolerance test. Ann N Y Acad Sci 1971; 191: 54–60.Google Scholar
  25. CS025.
    Lukas, M. C., and D. M. Temple. Some effects of chronic cannabis treatment. Aust J Pharm Sci 1974; 3(1): 20–22.Google Scholar
  26. CS026.
    El-Feraly, F. S., M. M. El-Sherei and F. J. Al-Muhtadi. Spiro-indans from Cannabis sativa. Phytochemistry 1986; 25(8): 1992–1994.Google Scholar
  27. CS027.
    Barrett, M. L., D. Gordon and F. J. Evans. Isolation from Cannabis sativa L. of cannflavin—A novel inhibitor of prostaglandin production. Biochem Pharmacol 1985; 34(11): 2019–2024.PubMedGoogle Scholar
  28. CS028.
    Barrett, M. L., A. M. Scutt and F. J. Evans. Cannflavin A and B, prenylated flavones from Cannabis sativa L. Experientia 1986; 42(4): 452–453.PubMedGoogle Scholar
  29. CS029.
    Sakakibara, I., T. Katsuhara, Y. Ikeya, K. Hayashi and H. Mitsuhashi. Cannabisin A, an arylnaphthalene lignanamide from fruits of Cannabis sativa. Phytochemistry 1991; 30(9): 3013–3016.Google Scholar
  30. CS030.
    Sakakibara, I., Y. Ikeya, K. Hayashi and H. Mitsuhashi. Three phenyldihydronaphthalene lignanamides from fruits of Cannabis sativa. Phytochemistry 1992; 31(P): 3219–3223.Google Scholar
  31. CS031.
    Sakakibara, I., Y. Ikeya, K. Hayashi, M. Okada and M. Maruno. Three acyclic bis-phenylpropane lignanamides from fruits of Cannabis sativa. Phytochemistry 1995; 38(4): 1003–1007.PubMedGoogle Scholar
  32. CS032.
    Taura, F., S. Morimoto and Y. Shoyama. Cannabinerolic acid, a cannabinoid from Cannabis sativa. Phytochemistry 1995; 39(2): 457–458.Google Scholar
  33. CS033.
    Barik, B. R., A. K. Dey and A. B. Kundu. Chemical constituents of Cannabis sativa. J Indian Chem Soc 1997; 74(8): 652.Google Scholar
  34. CS034.
    Zagari, A. Medicinal Plants. Vol 4, 5th Ed., Tehran University Publications, No 1810/4, Tehran, Iran, 1992; 4: 969 pp.Google Scholar
  35. CS035.
    Li, H. L. The origin and use of cannabis in Eastern Asia. Linguistic-cultural implications. Econ Bot 1974; 28: 293.Google Scholar
  36. CS036.
    Hendriks, H., T. M. Malingre, S. Batterman and R. Bos. Mono-and sesqui-terpene hydrocarbons of the essential oil of Cannabis sativa. Phytochemistry 1975; 14: 814–815.Google Scholar
  37. CS037.
    Thorburn, M. J. Jamaican bushes and human chromosomes. Jamaica J 1975; 8(4): 18.Google Scholar
  38. CS038.
    Latta, R. P. and B. J. Eaton. Seasonal fluctuations in cannabinoid content of Kansas marijuana. Econ Bot 1975; 29: 153.Google Scholar
  39. CS039.
    Turner, C. E. Active substances in marijuana. Arch Invest Med (Mex) 1974; 5S: 135.Google Scholar
  40. CS040.
    Rasmussen, K. E. and J. J. Herweijer. Examination of the cannabinoids in young cannabis plants. Pharm Weekl 1975; 110: 91.Google Scholar
  41. CS041.
    Paris, M., F. Boucher and L. Cosson. Importance of propyl compounds in cannabis originating in South Africa. Plant Med Phytother 1975; 9: 136.Google Scholar
  42. CS042.
    Payne, R. J. and S. N. Brand. The toxicity of intravenously used marihuana. JAMA 1975; 233: 351.PubMedGoogle Scholar
  43. CS043.
    Stromberg, L. Minor components of Cannabis resin: V. Mass spectrometric data and gas chromatographic retention times of cannabinoid components with retention times shorter than that of cannabidiol. J Chromatogr 1974; 96: 179.PubMedGoogle Scholar
  44. CS044.
    Turner, C. E., K. W. Hadley, J. H. Holley, S. Billets and M. L. Mole, Jr. Constituents of Cannabis sativa. VIII. Possible biological application of a new method to separate cannabidiol and cannabichromene. J Pharm Sci 1975; 64: 810.PubMedGoogle Scholar
  45. CS045.
    Alessandro, A., F. Mari and G. Mazzi. Rapid method for the identification of the active principles of Cannabis by circular thin-layer chromatography. Boll Chim Farm 1975; 114:21.PubMedGoogle Scholar
  46. CS046.
    Lee, C. K. Constituents of Korean cannabis. Yakhak Hoe Chi 1973; 17: 21.Google Scholar
  47. CS047.
    Bro, P., J. Schou and G. Topp. Cannabis poisoning with analytical verification. N Engl J Med 1975; 293:1049.PubMedGoogle Scholar
  48. CS048.
    Wheals, B. B. and R. N. Smith. Comparative cannabis analysis. A comparison of high-pressure liquid chromatography with other chromatographic techniques. J Chromatogr 1975; 105: 396–400.PubMedGoogle Scholar
  49. CS049.
    Turner, C. E., P. S. Fetterman, K. W. Hadley and J. E. Urbanek. Constituents of Cannabis sativa. X. Cannabinoid profile of a Mexican variant and its possible correlation to pharmacological activity. Acta Pharm Jugosl 1975; 25: 7.Google Scholar
  50. CS050.
    Slatkin, D. J., J. E. Knapp, P. L. Schiff, Jr., C. E. Turner and M. L. Mole, Jr. Steroids of Cannabis sativa root. Phytochemistry 1975; 14: 580–581.Google Scholar
  51. CS051.
    El-Feraly, F. S. and C. E. Turner. Alkaloids of Cannabis sativa leaves. Phytochemistry 1975; 14: 2304–2305.Google Scholar
  52. CS052.
    Sofia, R. D., H. B. Vassar and L. C. Knobloch. Comparative analgesic activity of various naturally occurring cannabinoids in mice and rats. Psychopharmacologia 1975; 40: 285.PubMedGoogle Scholar
  53. CS053.
    Malingre, T., H. Hendriks, S. Batter-man, R. Bos, and J. Visser. The essential oil of Cannabis sativa. Planta Med 1975; 28: 56.PubMedGoogle Scholar
  54. CS054.
    Zamir-Ul Hag, M., S. J. Rose, L. R. Deiderich and A. R. Patel. Identification and quantitative measurement of some n-heterocyclics in marijuana smoke condensates. Anal Chem 1974; 46: 1781.Google Scholar
  55. CS055.
    Smith, R. N. High-pressure liquid chromatography after injection of solid plant material and cold trapping. J Chromatogr 1975; 115: 101.PubMedGoogle Scholar
  56. CS056.
    Shani, A. and R. Mechoulam. Cannabielsoic acids: Isolation and synthesis by a novel oxidative cyclization. Tetrahedron 1974; 30: 2437.Google Scholar
  57. CS057.
    Coffman, C. B. and W. A. Gentner. Cannabis sativa. Effect of drying time and temperature on cannabinoid profile of stored leaf tissue. Bull Nar 1974; 26(1): 67.Google Scholar
  58. CS058.
    Dwivedi, C. and R. D. Harbison. Anticonvulsant activities of delta-8-and delta-9-tetrahydrocannabinol and uridine. Toxicol Appl Pharmacol 1975; 31:452.PubMedGoogle Scholar
  59. CS059.
    Romanenko, V. I. Changes in the physical and biochemical properties of hemp seeds during storage. Tr Vses Nauchno Issled Inst Lum Kuit 1974; 35: 80.Google Scholar
  60. CS060.
    Der Marderosian, A. H. and S. N. S. Murthy. Analysis of old samples of Cannabis sativa. J Forensic Sci 1974; 19: 670.Google Scholar
  61. CS061.
    Sallan, S. E., N. E. Zinberg and E. Frei. Antiemetic effect of delta-9-tetrahy-drocannabinol in patients receiving cancer chemotherapy. N Engl J Med 1975; 293: 795–797.PubMedGoogle Scholar
  62. CS062.
    Bercht, C. A. L. and M. R. Paris. Oil of Cannabis sativa. Bull Tech Gattefosse Sfpa 1973; 68: 87.Google Scholar
  63. CS063.
    Rasmussen, K. E. Quantitative determination of heptacosane and nonacosane in Norwegian-grown cannabis plants. Medd Nor Farm Selsk 1975; 37: 128.Google Scholar
  64. CS064.
    Turner, C. E., K. W. Hadley, J. Henry and M. L. Mole, Jr. Constituents of Cannabis sativa L. VII: Use of sialyl derivatives in routine analysis. J Pharm Sci 1974; 63:1872–1876.PubMedGoogle Scholar
  65. CS065.
    Clark, S. C., C. Greene, G. W. Karr, K. L. Mac Cannell and S. L. Milstein. Cardiovascular effects of marihuana in man. Can J Physiol Pharmacol 1974; 52: 706.PubMedGoogle Scholar
  66. CS066.
    Le Vander, S., M. Binder, S. Agurell, A. Bader-Bartfai, B. Gustafsson, K. Leander, J. E. Lindgren, A. Olsson and B. Tobisson. Pharmacokinetics in relation to physiological effects of delta-8-thc (delta-8-thiocarbanidin). Acta Pharm Suesica 1974; 11: 662.Google Scholar
  67. CS067.
    Paris, M., F. Boucher and L. Cosson. The constituents of Cannabis sativa pollen. Econ Bot 1975; 29: 245–253.Google Scholar
  68. CS068.
    Hanus, L. The present state of knowledge in the chemistry of substances of Cannabis sativa. III. Terpenoid substances. Acta Univ Palacki Olomuc Fac Med 1975; 73: 233.Google Scholar
  69. CS069.
    Stromberg, L. Minor components of cannabis resin. IV. Mass spectrometric data and gas chromatographic retention times of terpenic components with retention times shorter than that of cannabidiol. J Chromatogr 1974; 96: 99.PubMedGoogle Scholar
  70. CS070.
    Hanus, L. The present state of knowledge in the chemistry of substances of Cannabis sativa. IV. Nitrogen containing compounds. Acta Univ Palacki Olomuc Fac Med 1975; 73: 241.Google Scholar
  71. CS071.
    Takatsuto, S. R., H. Y. Abe, T. K. Yokota, K. Y. Shimada and K. J. Gamoh. Identification of castasterone and teasterone in seeds on Cannabis sativa L. Nihon Yukagakkaishi 1996; 45(9): 871–873.Google Scholar
  72. CS072.
    Kausar, W., A. Muhammad and I. Ul-Haq. Effect of cannabis on intraocular pressure. Pak J Pharmacol 1995; 12(2): 43–48.Google Scholar
  73. CS073.
    Morimoto, S., K. Komatsu, F. Taura and Y. Shoyama. Enzymological evidence for cannabichromenic acid biosynthesis. J Nat Prod 1997; 60(8): 854–857.Google Scholar
  74. CS074.
    Smith, R. M. Identification of butyl cannabinoids in marijuana. J Forensic Sci 1997; 42(4): 610–618.Google Scholar
  75. CS075.
    Shin, N. H., K. S. Lee, S. H. Kang, K. R. Min, S. H. Lee and Y. S. Kim. Inhibitory effects of herbal extracts on dopa oxidase activity of tyrosinase. Nat Prod Sci 1997; 3(2): 111–121.Google Scholar
  76. CS076.
    Takasuto, S., T. Kawashima, T. Noguchi, S. Fujioka and A. Sakurai. Identification of teasterone and phytosterols in the lip id fraction from seeds of Cannabis sativa L. Nihon Yukagakkaishi 1997; 46(12): 1499–1504.Google Scholar
  77. CS077.
    Takasuto, S. and T. Kawashima. Identification of 24-methyl-5-alpha-cholestan-3-one and 24-methylcholest-4-en-3-one in the seeds of Cannabis sativa L. Nihon Yukagakkaishi 1998; 47(8): 783–786.Google Scholar
  78. CS078.
    Graham, J. D. P., B. H. Davies, A. Seaton and R. M. Weatherstone. Bronchodilator action of extract of cannabis and delta-1-tetrahydrocan-nabinol. Pharmacol Marihuana Braude MC Szara S (Eds) Raven Press New York 1976; 1: 269–276.Google Scholar
  79. CS079.
    Chan, W. R., K. E. Magnus and H. A. Watson. The structure of cannabitriol. Experientia 1976; 32: 283.PubMedGoogle Scholar
  80. CS080.
    Ottersen, T., A. Aasen, F. S. El-Feraly and C. E. Turner. X-ray structure of cannabispiran: A novel cannabis constituent. Chem Commun 1976; 1976; 580.Google Scholar
  81. CS081.
    Wold, J. K. and A. Hillestad. The demonstration of galactosamine in a higher plant: Cannabis sativa. Phytochemistry 1976; 15: 325B–326B.Google Scholar
  82. CS082.
    Krishnamurty, H. G. and R. Kaushal. Free sugars & cyclitols of Indian marihuana (Cannabis sativa). Indian J Chem 1976; 14B: 639.Google Scholar
  83. CS083.
    Itokawa, H., K. Takeya and M. Akasu. Studies on the constituents isolated from the callus of Cannabis sativa. Shoyakugaku Zasshi 1975; 29:106–112.Google Scholar
  84. CS084.
    Stromberg, L. Minor components of cannabis resin. VI. Mass spectrometric data and gas chromatographic retention times of components eluted after cannabinol. J Chromatogr 1976; 121:313.PubMedGoogle Scholar
  85. CS085.
    Turner, C. E., M. F. H. Hsu, J. E. Knapp, P. L. Schiff, Jr. and D. J. Slatkin. Isolation of cannabisativine, an alkaloid from Cannabis sativa root. J Pharm Sci 1976; 65: 1084.PubMedGoogle Scholar
  86. CS086.
    Tatkon, M. The practice of a Jaipur midwife. Ethnomedicine 1976; 2; 59.Google Scholar
  87. CS087.
    Wright, P. L., S. H. Smith, M. L. Keplinger, J. C. Calandra and M. C. Braude. Reproductive and teratologic studies with delta 9-tetrahydrocan-nabinol and crude marijuana extract. Toxicol Appl Pharmacol 1976; 38: 223.PubMedGoogle Scholar
  88. CS088.
    Novotny, M., M. L. Lee and K. D. Bartle. A possible chemical basis for the higher mutagenicity of marijuana smoke as compared to tobacco smoke. Experientia 1976; 32: 280.PubMedGoogle Scholar
  89. CS089.
    Liu, T. C., Y. Zhang, G. Liu and J. Chen. Determination of delta 9-tetrahydrocannabinol, cannabinol, and cannabinol in Xinjiang cannabis plant by GC. Chung Ts’ao Yao 1992; 23(9): 463–464.Google Scholar
  90. CS090.
    Bhattarai, N. K. Folk use of plants in veterinary medicine in Central Nepal. Fitoterapia 1992; 63(6): 497–506.Google Scholar
  91. CS091.
    Elsohly, H. N. and C. E. Turner. Constituents of Cannabis sativa L. XXII: Isolation of spiro-indan and dihydrostilbene compounds from a Panamanian variant grown in Mississippi, United States of America. Bull Nar 1982; 34(2): 51–56.Google Scholar
  92. CS092.
    Sakakibara, I., H. Mihashi, T. Fujihashi and A. Okuma. Antitumor agents containing N-(P-coumaroyl)tyramine. Patent-Japan Kokai Tokkyo Koho—04 1992; 26, 622: 6 pp.Google Scholar
  93. CS093.
    Sakakibara, I., H. Mihashi, J. Hayashi and M. Chin. Novel liganamides and protease inhibitors-containing them. Patent-Japan Kokai Tokkyo Koho—05 1993; 25,110: 10 pp.Google Scholar
  94. CS094.
    Kurokawa, M., H, Ochiai, K. Nagasaka, M. Neki, H. X. Xu, S. Kadota, S. Sutardio, T. Matsumoto, T. Namba and K. Shiraki. Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and Measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice. Antiviral Res 1993; 22(2/3): 175–188.PubMedGoogle Scholar
  95. CS095.
    Makler, M. T. The effect of cocaine on the growth of Plasmodium falciparum in vitro. Trans Roy Soc Trop Med Hyg 1994; 88(4): 444.PubMedGoogle Scholar
  96. CS096.
    Singh, J., A. K. Dubey and N. N. Tripathi. Antifungal activity of Mentha spicata. Int J Pharmacog 1994; 32(4): 314–319.Google Scholar
  97. CS097.
    El-Fickey, M. S., A. A. El-Tomey and S. F. Mahmoud. Effect of cannabis on gastric secretion and on stress-induced gastric ulcers in albino rats. Exp Clin Gastroenterol 1993; 3(1): 55–58.Google Scholar
  98. CS098.
    Singh, K. K. and J. K. Maheshwari. Traditional phytotherapy of some medicinal plants used by the Tharus of the Nainital District, Uttar Pradesh, India. Int J Pharmacog 1994; 32(1): 51–58.Google Scholar
  99. CS099.
    Anis, M. and M. Iqbal. Medicinal plantlore of Aligarh, India. Int J Pharmacog 1994; 32(1): 59–64.Google Scholar
  100. CS100.
    Bhattarai, N. K. Folk herbal remedies for gynaecological complaints in central Nepal. Int J Pharmacog 1994; 32(1): 13–26.Google Scholar
  101. CS101.
    Kim, S. Y., J. H. Kim, S. K. Kim, M. J. Oh and M. Y. Jung. Antioxidant activities of selected Oriental herb extracts. J Amer Oil Chem Soc 1994; 71(6): 633–640.Google Scholar
  102. CS102.
    Hammond, C. T. and P. G. Mahlberg. Phloroglucinol glucoside as a natural constituent of Cannabis sativa. Phytochemistry 1994; 37(3): 755–756.Google Scholar
  103. CS103.
    Kataoka, M. and Y. Takagaki. Effect of the crude drugs (standards of natural drugs not in the J. P. XII) on beta-hexosaminidase release from rat basophilic leukemia (RBL-2H3) cells. Nat Med 1995; 49(3): 346–349.Google Scholar
  104. CS104.
    Bhattarai, N. K. Folk anthelmintic drugs of Central Nepal. Int J Pharmacol 1992; 30(2): 145–150.Google Scholar
  105. CS105.
    Manandhar, N. P. Herbal remedies of Surkhet District, Nepal. Fitoterapia 1993; 64(3): 266–272.Google Scholar
  106. CS106.
    Giron, L. M., V. Freire, A. Alonzo and A. Caceres. Ethnobotanical survey of the medicinal flora used by the Caribs of Guatemala. J Ethnopharmacol 1991; 34(2/3): 173–187.PubMedGoogle Scholar
  107. CS107.
    Simon, C. and M. Lamla. Merging pharmacopoeia: Understanding the historical origins of incorporative pharmacopoeial processes among Xhosa healers in Southern Africa. J Ethnopharmacol 1991; 33(3): 237–242.PubMedGoogle Scholar
  108. CS108.
    Singh, V. K., Z. A. Ali and M. K. Siddioui. Ethnomedicines in the Bahraich District of Uttar Pradesh, India. Fitoterapia 1996; 67(1): 65–76.Google Scholar
  109. CS109.
    Li, H. L. Hallucinogenic plants in Chinese herbals. Bot Mus Leafl Harv Univ 1977; 25(6): 161–181.Google Scholar
  110. CS110.
    Bhattarai, N. K. Medical ethnobotany in the Rapti Zone, Nepal. Fitoterapia 1993; 64(6): 483–493.Google Scholar
  111. CS111.
    Bellakhdar, J., R. Claisse, J. Fleurentin and C. Younos. Repertory of standard herbal drugs in the Moroccan pharmacopoeia. J Ethnopharmacol 1991; 35(2): 123–143.PubMedGoogle Scholar
  112. CS112.
    Duke, J. A. and E. S. Ayensu. Medicinal Plants of China. Reference Publications, Inc. Algonac, Michigan 1985; 1(4): 52–361.Google Scholar
  113. CS113.
    Leporatti, M. L. and E. Lattanzi. Traditional phytotherapy on coastal areas on Makran (Southern Pakistan). Fitoterapia 1994; 65(2): 158–161.Google Scholar
  114. CS114.
    Smith, R. M. and K. D. Kempfert. Delta-1-3,4-cis-tetrahydrocannabinol in Cannabis sativa. Phytochemistry 1977; 16: 1088–1089.Google Scholar
  115. CS115.
    Uliss, D. B., G. R. Handrick, H. C. Dalzell and R. K. Razdan. A novel cannabinoid containing a 1,8-cineol moiety. Experientia 1977; 33: 577.PubMedGoogle Scholar
  116. CS116.
    Smith, R. N., L. V. Jones, J. S. Brennan and C. G. Vaughan. Identification of hexadecanamide in cannabis resin. J Pharm Pharmacol 1977; 29(2): 126–127.PubMedGoogle Scholar
  117. CS117.
    Diaz, J. L. Ethnopharmacology of sacred psychoactive plants used by the Indians of Mexico. Ann Rev Pharmacol Toxicol 1977; 17:647.Google Scholar
  118. CS118.
    El Sohly, M. A., F. S. El-Feraly and C. E. Turner. Isolation and characterization of (+)-cannabitriol and (−)-10-ethoxy-9-hydroxy-delta 6A(10A)-tetrahydrocannabinol: Two new cannabinoids from Cannabis sativa L. extract. Lloydia 1977; 40(3): 275.Google Scholar
  119. CS119.
    Hillestad, A., J. K. Wold and T. Engen. Water-soluble glycoproteins from Cannabis sativa (Thailand). Phytochemistry 1977; 16: 1953–1956.Google Scholar
  120. CS120.
    Feeney, D. M. Marihuana and epilepsy. Science 1977; 197: 1301.PubMedGoogle Scholar
  121. CS121.
    Segelman, A. B., F. P. Segelman, S. D. Varma, H. Wagner and O. Seligmann. Cannabis sativa L. (marijuana) IX. Lens aldose reductase inhibitory activity of marijuana flavone c-glycosides. J Pharm Sci 1977; 66(9): 1358–1359.PubMedGoogle Scholar
  122. CS122.
    Sethi, V. K., M. P. Jain and R. S. Thakur. Chemical investigation of wild Cannabis sativa roots. Planta Med Suppl 1977; 32: 378–379.Google Scholar
  123. CS123.
    Lewis, W. H. and M. P. F. Elvin-Lewis. Medical Botany. Wiley-Interscience, New York, 1977.Google Scholar
  124. CS124.
    Bercht, C. A. L., J. P. C. M. Van Dongen, W. Heerman, R. J. J. C. Lousberg and F. J. E. M. Kuppers. Cannabispirone and cannabispirenone, two naturally occurring spiro-compounds. Tetrahedron 1976; 32: 2939.Google Scholar
  125. CS125.
    Rana, T. S. and B. Datt. Ethnobotanical observation among Jaunsar-Bawar, Dehra Dun (J. P.), India. Int J Pharmacog 1997; 35(5): 371–374.Google Scholar
  126. CS126.
    Matsunaga, T., K. Watanabe, H. Yoshimura and I. Yamamoto. Quantitative analysis and pharmaco-toxicity of cannabinoids in commercially available cannabis seeds. Yakugaku Zasshi 1998; 118(9): 408–414.PubMedGoogle Scholar
  127. CS127.
    Rajurkar, N. S. and B. M. Pardeshi. Analysis of some herbal plants from India used in the control of diabetes mellitus by NAA and AAS techniques. Appl Radiat Isot 1997; 48(8): 1059–1062.PubMedGoogle Scholar
  128. CS128.
    Toda, M., J. Kawabata and T. Kasai. Alpha-glucosidase inhibitors from glove (Syzygium aromaticum). Biosci Biotech Biochem 2000; 64(2): 294–298.Google Scholar
  129. CS129.
    Duncan, A. C., A. K. Jager and J. Van Staden. Screening of Zulu medicinal plants for angiotensin converting enzyme (ACE) inhibitors. J Ethnopharmacol 1999; 68(1/3): 63–70.PubMedGoogle Scholar
  130. CS130.
    Rifka, S. M., M. Sauer, R. L. Hawks, G. B. Cutler and D. L. Loriaux. Marijuana as an estrogen. Proc Endocrine Soc 60th Ann Mtg, Miami Beach, Florida, June 14–16, 1978; 1978: 200.Google Scholar
  131. CS131.
    Segelman, A. B., F. P. Segelman, A. E. Star, H. Wagner and O. Seligmann. Cannabis sativa. Part 8. Structure of two-c-diglycosylflavones from Cannabis sativa. Phytochemistry 1978; 17: 824–826.Google Scholar
  132. CS132.
    Grote, H. and G. Spiteller. New cannabinoids. II. J Chromatogr 1978; 154: 13.Google Scholar
  133. CS133.
    Gigliano, G. S. Cannabinols in Cannabis sativa L. under different cultivation conditions. Bull Chem Farm 1984; 123(7): 352–356.Google Scholar
  134. CS134.
    Lawi-Berger, C. and I. Kapetanidis. Chemotaxonomic study of cannabis (Cannabaceae). Part 2. Quantitative analysis of fatty acids in hemp seeds of Cannabis sativa L. Pharm Acta Helv 1983; 58(3): 79–81.Google Scholar
  135. CS135.
    El-Sherei, M. M. and F. S. El-Feraly. New spiroindans from cannabis. Abstr Internat Res Cong Nat Prod Coll Univ Univ N Carolina Chapel Hill NC July 7–12 1985 1985; ABSTR-56.Google Scholar
  136. CS136.
    El Sohly, M. A., J. H. Holley and C. E. Turner. Constituents of Cannabis sativa L. XXVI. The delta-9-tetrahydro-cannabinol content of confiscated marijuana, 1974–1983. Proc Oxford Symp Cannabis 1985; 1984: 37–42.Google Scholar
  137. CS137.
    Morita, M. and H. Ando. Analysis of hashish oil by gas chromatography / mass spectrometry. Kagaku Keisatsu Kenkyusho Hokoku Hokagaku Hen 1984; 37(2): 137–140.Google Scholar
  138. CS138.
    Hodges, L. C., H. M Deutsch, K. Green and L. H. Zalkow. Polysaccharides from Cannabis sativa active in lowering intraocular pressure. Carbohydr Polym 1985; 5(2): 141–154.Google Scholar
  139. CS139.
    Kubo, M., H. Matsuda, M. Fukui and Y. Nakai. Development studies of cuticle drugs from natural resources. I. Effects of crude drug extracts on hair growth in mice. Yakugaku Zasshi 1988; 108(10): 971–978.PubMedGoogle Scholar
  140. CS140.
    Formukong, E. A., A. T. Evans and F. J. Evans. Analgesic and antiinflammatory activity of constituents of Cannabis sativa L. Inflammation (NY) 1988; 12(4): 361–371.Google Scholar
  141. CS141.
    Sethi, N., P. K. Agnihotri and S. Srivastava. Aminopyrine-n-demethylase activity of rat liver after administration of crude cannabis extract. Indian J Med Res 1989; 90(1): 36–38.PubMedGoogle Scholar
  142. CS142.
    Deutsch, H. M., K. Green and L. H. Zalkow. Water soluble high molecular weight components from plants with potent intraocular pressure lowering activity. Curr Eye Res 1987; 6(7): 949–950.PubMedGoogle Scholar
  143. CS143.
    Shah, N. C. and S. K. Jain. Ethno-medico-botany of the Kumaon Himalaya, India. Social Pharmacol 1988; 2(4): 359–380.Google Scholar
  144. CS144.
    Sato, A. Studies on anti-tumor activity of crude drugs. 1. The effects of aqueous extracts of some crude drugs in short-term screening test. Yakugaku Zasshi 1989; 109(6): 407–423.PubMedGoogle Scholar
  145. CS145.
    Ilanus, L. and K. Tesarik. Capillary gas chromatography of natural substances from Cannabis sativa L. III. Content of cannabinoids in dried roots. Acta Univ Palacki Olomuc Fac Med 1987; 116:31–35.Google Scholar
  146. CS146.
    Hanus, L., C. E. Turner and M. A. El Sohly. Isolation and identification of propylcannabinoids from Soviet variety of hemp grown in Mississippi. Acta Univ Palacki Olomuc Fac Med 1987; 116:25–30.PubMedGoogle Scholar
  147. CS147.
    Vidal, C., R. Fuente, A. Iglesias and A. Saez. Bronchial asthma due to Cannabis sativa seed. Allergy 1991; 46(8): 647–650.PubMedGoogle Scholar
  148. CS148.
    Matsunaga, T., H. Nagatomo, I. Yamamoto and H. Yoshimura. Qualitative and quantitative analyses of cannabinoids in cannabis seeds. Hochudoku 1990; 8(2): 88–89.Google Scholar
  149. CS149.
    Matsunaga, T., K. Watanabe, I. Yamamoto and H. Yoshimura. Analyses of nitrogenous constituents in Cannabis sativa L. Hochudoku 1991; 9(2): 122–123.Google Scholar
  150. CS150.
    Grote, H. and G. Spitteler. New cannabinoids. III. The structure of cannabicoumaronone. Tetrahedron 1978; 34: 3207.Google Scholar
  151. CS151.
    Kanter, S. L., M. R. Musumeci and L. E. Hollister. Quantitative determination of delta9-tetrahydrocannabinol and delta9-tetrahydrocannabinolic acid in marihuana by high-pressure liquid chromatography. J Chromatogr 1979; 171:504.PubMedGoogle Scholar
  152. CS152.
    Fournier, G., M. R. Paris, M. C. Fourniat and A. M. Quero. Bacteriostatic effect of essential oil from Cannabis sativa. Ann Pharm Fr 1978; 36: 603.PubMedGoogle Scholar
  153. CS153.
    Cutler, M. G., J. H. Mackintosh and M. R. A. Chance. Cannabis resin and sexual behaviour in the laboratory mouse. Psychopharmacologia 1975; 45: 129.Google Scholar
  154. CS154.
    Burton, T. A. Urinary retention following cannabis ingestion. JAMA 1979; 242: 351.PubMedGoogle Scholar
  155. CS155.
    Kettenes Van Den Bosch, J. J. and C. A. Salemink. Cannabis. XIX. Oxygenated 1,2-diphenylethanes from marihuana. Recl Trav Chim Pays-Bas 1978; 97: 221–222.Google Scholar
  156. CS156.
    Hendriks, H., T. M. Malingre, S. Batterman and R. Bos. The essential oils of Cannabis sativa. Pharm Weekl 1978; 113:413–424.Google Scholar
  157. CS157.
    Crombie, L. and W. M. L. Crombie. Dihydrostilbenes of Thailand cannabis. Tetrahedron Lett 1978; 1978: 4711–4714.Google Scholar
  158. CS158.
    El Sohly, M. A., E. G. Boeren and C. E. Turner. (DL)-9-10-dihydroxy-delta-6(A)(10A)-tetrahydrocannabinol and (DL)-8,9-dihydroxy-delta-6(A)(10A)-tetrahydrocannabinol. Two new cannabinoids from Cannabis sativa L. Experientia 1978; 34: 1127–1128.Google Scholar
  159. CS159.
    Burstein, S., P. Taylor, F. S. El-Feraly and C. E. Turner. Prostaglandins and cannabis—V. Identification of paravinylphenol as a potent inhibitor of prostaglandin synthesis. Biochem Pharmacol 1976; 25: 2003–2004.PubMedGoogle Scholar
  160. CS160.
    Mendelson, J. H., J. Ellingboe and J. C. Kuehnle. Effects of alcohol and marihuana on plasma luteinizing hormone and testosterone. Probl Drug Depend 1976; 1976: 525–537.Google Scholar
  161. CS161.
    Ayensu, E. S. Medicinal Plants of the West Indies. Unpublished Manuscript 1978; 110 pp.Google Scholar
  162. CS162.
    Okey, A. B. and G. P. Bondy. Is delta-9-tetrahydrocannabinol estrogenic? Comments. Science 1977; 195: 904–905.PubMedGoogle Scholar
  163. CS163.
    Soni, C. M. and M. L. Gupta. Effect of cannabis (bhang) extract on blood glucose and liver glycogen in albino rats. Indian J Physiol Pharmacol 1978; 22: 152–154.PubMedGoogle Scholar
  164. CS164.
    Hembree III, W. C., G. G. Nahas, P. Zeidenberg and H. F. S. Huang. Changes in human spermatozoa associated with high dose marihuana smoking. Adv Biosci 1979; 1979: 429–439.Google Scholar
  165. CS165.
    Boeren, E. G., M. A. El Sohly and C. E. Turner. Cannabiripsol: A novel cannabis constituent. Experientia 1979; 35: 1278–1279.PubMedGoogle Scholar
  166. CS166.
    Waddell, T. G., H. Jones and A. L. Keith. Legendary chemical aphrodisiacs. J Chem Ed 1980; 57; 341–342.Google Scholar
  167. CS167.
    Cozens, D. D., R. Clark, A. K. Palmer, N. Hardy, G. G. Nahas and D. J. Harvey. The effect of a crude marihuana extract on embryonic and fetal development of the rabbit. Adv Biosci Marihuana Biological Effects 1978; 22: 469–477.Google Scholar
  168. CS168.
    Fujimoto, G. I., A. B. Kostellow, R. Rosenbaum, G. A. Morrill and E. Bloch. Effects of cannabinoids on reproductive organs in the female Fischer rat. Adv Biosci Marihuana Biological Effects 1978; 22: 441–447.Google Scholar
  169. CS169.
    Tucakov, J. Ethnophytotherapy of diabetes. Srp Arh Celok Lek 1978; 106: 159–173.PubMedGoogle Scholar
  170. CS170.
    Kostellow, A. B., D. Ziegler, J. Kunar, G. I. Fujimoto and G. A. Morrill. Effect of cannabinoids on estrous cycle, ovulation, and reproduction capacity of female A/J mice. Pharmacology 1980; 21: 68–75.PubMedGoogle Scholar
  171. CS171.
    Gawin, F. H. Drugs and Eros: Reflection on aphrodisiacs. J Psychodelic Drugs 1978; 10: 227–236.Google Scholar
  172. CS172.
    Turner, C. E., M. A. El Sohly and E. G. Boeren. Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J Nat Prod 1980; 43(2): 169–234.PubMedGoogle Scholar
  173. CS173.
    Dixit, V. P. Effects of Cannabis sativa extract on testicular function of Presbytis entellus. Planta Med 1981; 41: 288–294.PubMedGoogle Scholar
  174. CS174.
    Dixit, V. P., M. Arya and N. K. Lohiya. The effect of chronically administered cannabis extract on the female genital tract of mice and rats. Endokrinologie 1975; 66: 365–368.PubMedGoogle Scholar
  175. CS175.
    Chakravarty, I. and D. Sengupta. Effect of cannabis extract on uterine phosphatase activities in prepubertal rats. IRCS Med Sci Biochem 1980; 8:25.Google Scholar
  176. CS176.
    Rizvi, S. J. H., D. Mukerji and S. N. Mathur. A new report of some possible source of natural herbicide. Indian J ExpBiol 1980; 18:777–781.Google Scholar
  177. CS177.
    Chen, Y. J., C. H. Yu, S. S. Wang, J. Che, Y. Y. Kuo, W. S. Chen, Y. P. Cheng, Y. L. Liu and S. S. Yiu. Studies on the active principles in leaves of Cannabis sativa. Chung Ts’ao Yao 1981; 12(3): 44.Google Scholar
  178. CS178.
    Abel, E. L., B. A. Dintcheff and N. Day. Effects of marihuana on pregnant rats and their offspring. Psychopharmacology (Berlin) 1980; 71: 71–74.Google Scholar
  179. CS179.
    Yotoriyama, M., I. Ito, D. Takashima, Y. Shoyama and I. Nishioka. Plant breeding of cannabis. Determination of cannabinoids by high-pressure liquid chromatography. Yakugaku Zasshi 1980; 100:611–614.PubMedGoogle Scholar
  180. CS180.
    Turner, C. E. and H. N. El Sohly. Isocannabispiran, a new spiro-compound isolated from a Panamanian variant of Cannabis sativa L. Abstr Joint Meeting American Society of Pharmacognosy and Society for Economic Botany Boston July 13–17 1981: 14.Google Scholar
  181. CS181.
    Nahas, G. G. Marijuana and sex. Med Aspects Human Sexuality 1981; 15(12): 30–39.Google Scholar
  182. CS182.
    Crombie, L., W. M. L. Crombie and S. V. Jamieson. Extractives of Thailand cannabis: Synthesis of canniprene and isolation of new geranylated and prenylated chrysoeriols. Tetrahedron Lett 1980; 21: 3607–3610.Google Scholar
  183. CS183.
    Dalterio, S., F. Badr, A. Bartke and D. Mayfield. Cannabinoids in male mice: Effects on fertility and spermatogenesis. Science 1982; 216: 315–316.PubMedGoogle Scholar
  184. CS184.
    Dixit, V. P., M. Arya and N. K. Lohiya. Mechanism of action of chronically administered cannabis extract on the female genital tract of gerbils. Indian J Physiol Pharmacol 1976; 20: 38–41.PubMedGoogle Scholar
  185. CS185.
    Crombie, L. and W. M. L. Crombie. Natural products of Thailand high delta-1-THC-strain cannabis. The bibenzyl-spiran-dihydrophenanthrene group: Relations with cannabinoids and canniflavones. J Chem Soc Perkin Trans I 1982; 1982: 1455–1466.Google Scholar
  186. CS186.
    Hong, C. Y., D. M. Chaput de Saintonge, P. Turner and J. W. Fairbairn. Comparison of the inhibitory action of delta-9-tetrahydrocannabinol and petroleum spirit extract of herbal cannabis on human sperm motility. Human Toxicol 1982; 1: 151–154.Google Scholar
  187. CS187.
    Lares, A., Y. Ochoa, A. Bolanos, N. Aponte and M. Montenegro. Effects of the resin and smoke condensate of Cannabis sativa on the oestrous cycle of the rat. Bull Nar 1981; 33(3): 55–61.Google Scholar
  188. CS188.
    Heitrich, A. and M. Binder. Identification of (3R,4R)-delta-1-(6)-tetrahydrocannabinol as an isolation artifact of cannabinoid acids formed by callus cultures of Cannabis sativa L. Experientia 1982; 38: 898–899.Google Scholar
  189. CS189.
    Frischknecht, H. R., B. Sieber and P. G. Waser. Effects of multiple, chronic and early hashish exposure on mating behavior, nest-building, and gestation in mice. Comp Biochem Physiol 1982; 77: 363–368.Google Scholar
  190. CS190.
    El-Zawahri, M. M. and A. F. Khishin. Mutagenic effect of cannabis. Adv Genet Dev Evol Drosophila (7th Proc Eur Drosophila Res Conf) 1982; 1982: 101–107.Google Scholar
  191. CS191.
    Green, K., L. H. Zalkow, H. M. Deutsch, M. E. Yablonski, N. Oliver, C. M. Symonds and R. D. Elijah. Ocular and systemic responses to water-soluble material. Curr Eye Res 1981; 1(2): 65–75.PubMedGoogle Scholar
  192. CS192.
    Shah, N. C. Herbal folk medicines in Northern India. J Ethnopharmacol 1982; 6(3): 293–301.PubMedGoogle Scholar
  193. CS193.
    Lal, S. D. and B. K. Yadav. Folk medicine of Kurushetra District (Haryana), India. Econ Bot 1983; 37(3): 299–305.Google Scholar
  194. CS194.
    Mc Phail, A. T., H. N. El Sohly, C. E. Turner and M. A. El Sohly. Stereochemical assignments for the two enantiomeric pairs of 9,10-dihydroxy-delta-6-alpha(10-alpha)-tetrahydro-cannabinols. X-ray crystal structure analysis of (DL)-trans-cannabitriol. Abstr 24th Annual Meeting American society of Pharmacognosy Univ Mississippi Oxford July 24–28 1983: ABSTR-50.Google Scholar
  195. CS195.
    Papadakis, D. P., C. A. Salemink, F. J. Alikaridis and T. A. Kephalas. Isolation and identification of new cannabinoids in cannabis smoke. Tetrahedron 1983; 39(13): 2223–2225.Google Scholar
  196. CS196.
    Lemberkovics, E., P. Veszki, G. Verzar-Petri and A. Trka. Study on sesquiterpenes of the essential oil in the inflorescence and leaves of Cannabis sativa L. var. Mexico Sci Pharm 1981; 49: 401–408.Google Scholar
  197. CS197.
    Zhu, R. K., M. S. Zhou, B. J. Lee and L. Lee. Clinical study on the treatment of psoriasis with “ke-yin” (anti-psoriasis) prescription. Chung I Tsa Chih 1981; 22(4): 22–24.Google Scholar
  198. CS198.
    Morrison, E. Y. S. A. and M. West. A preliminary study of the effects of some West Indian medicinal plants on blood sugar levels in the dog. West Indian Med J 1982; 31: 194–197.PubMedGoogle Scholar
  199. CS199.
    Morimoto, I., F. Watanabe, T. Osawa, T. Okitsu and T. Kada. Mutagenicity screening of crude drugs with Bacillus subtilis rec-assay and Salmonella/micro-some reversion assay. Mutat Res 1982; 97: 81–102.PubMedGoogle Scholar
  200. CS200.
    Vijayalakshimi, K., S. D. Mishra and S. K. Prasad. Nematicidal properties of some indigenous plant materials against second stage juveniles of Meloidogyne incognita (Koffoid and White) Chitwood. Indian J Entomol 1979; 41(4): 326–331.Google Scholar
  201. CS201.
    Rouquayrol, M. Z., M. C. Fonteles, J. E. Alencar, F. Jose De Abreu Matos and A. A. Craveiro. Molluscicidal activity of essential oils from Northeastern Brazilian plants. Rev Brasil Pesq Med Biol 1980; 13: 135–143.Google Scholar
  202. CS202.
    El-Feraly, F. S. Isolation, characterization and synthesis of 3,5,4′-trihydroxy-bibenzyl from Cannabis sativa. J Nat Prod 1984; 47(1): 89–92.Google Scholar
  203. CS203.
    Mc Phail, A. T., H. N. El Sohly, C. E. Turner and M. A. El Sohly. Stereochemical assignments for the two enantiomeric pairs of 9,10-dihydroxy-delta-6A(10A)-tetrahydrocannabinols. X-ray crystal structure analysis of DL-trans-cannabitriol. J Nat Prod 1984; 47(1): 138–142.Google Scholar
  204. CS204.
    El Sohly, H. N., G. E. Ma, C. E. Turner and M. A. El Sohly. Constituents of Cannabis sativa. XXV. Isolation of two new dihydrostilbenes from a Panamanian variant. J Nat Prod 1984; 47(3): 445–452.Google Scholar
  205. CS205.
    El Sohly, H. N., E. G. Boeren, C. E. Turner and M. A. El Sohly. Constituents of Cannabis sativa L. XXIIII: Cannabitetrol, a new polyhydroxylated cannabinoid. Cannabinoids Chem Pharmacol Ther Aspects (PAP Meet) 1984: 89–96.Google Scholar
  206. CS206.
    El Sohly, M. A., J. H. Holley, G. S. Lewis, M. H. Russell and C. E. Turner. Constituents of Cannabis sativa L. XXIV. The potency of confiscated marijuana, hashish, and hash oil over a ten-year period. J Forensic Sci 1984; 1984(4): 500–514.Google Scholar
  207. CS207.
    Hardman, J. T., M. L. Beck and C. E. Owensby. Range forb lectins. Transfusion 1983; 23(6): 519–522.PubMedGoogle Scholar
  208. CS208.
    Mendelson, J. H., J. Ellingboe, J. C. Kuehnle and N. K. Mello. Effects of chronic marihuana use on integrated plasma testosterone and luteinizing hormone levels. J Pharmacol Exp Ther 1978; 207: 611–617.PubMedGoogle Scholar
  209. CS209.
    El Sohly, H. N. and C. E. Turner. Constituents of Cannabis sativa L. XXII. Isolation of spiro-indan and dihydrostilbene compounds from a Panamanian variant grown in Mississippi, United States of America. Bull Nar 1982; 34(2): 51–56.Google Scholar
  210. CS210.
    Flint, M. Lockmi: An Indian midwife. Anthropology of Human Birth 1982: 211–219.Google Scholar
  211. CS211.
    Hendriks, H., S. Batterman, R. Bos, H. J. Huizing and T. M. Malingre. Use of amberlite XAD-2 columns for the separation of cannabinoids from cannabis extracts. J Chromatogr 1981; 205: 444–450.Google Scholar
  212. CS212.
    Singh, K. V. and R. K. Pathak. Effect of leaves extracts of some higher plants on spore germination of Ustilago maydes and U. nuda. Fitoterapia 1984; 55(5): 318–320.Google Scholar
  213. CS213.
    Jain, S. P. and H. S. Puri. Ethnomedical plants of Jaunsar-Bawar Hills, Uttar Pradesh, India. J Ethnopharmacol 1984; 12(2): 213–222.PubMedGoogle Scholar
  214. CS214.
    Khan, N. A. and S. S. Hasan. Effect of cannabis hemp (hashish) on normal and rats subjected to psychological stress. Proc Indian Acad Sci Anim Sci 1984; 93(2): 121–129.Google Scholar
  215. CS215.
    Fujimoto, G. I., L. C. Krey and L. Macedonia. Effect of chronic cannabinoid treatment on androgenic stimulation of male accessory sex organs in the rat. Cannabinoids: Chem Pharmacol Ther Aspects (PAP Meet) 1984: 401–410.Google Scholar
  216. CS216.
    Dixit, V. P., H. C. Jain, O. P. Verma and A. N. Sharma. Effects of cannabis extract on the testicular function of the toad Bufo andersonii Boulenger. Indian J Exp Biol 1977; 15: 555–556.PubMedGoogle Scholar
  217. CS217.
    Sahu, T. R. Less known uses of weeds as medicinal plants. Ancient Sci Life 1984; 3(4): 245–249.Google Scholar
  218. CS218.
    Hanus, L., K. Tesarik and Z. Krejci. Capillary gas chromatography of natural substances from Cannabis sativa L. I. Cannabinol and cannabinolic acid—Artefacts. Acta Univ Palacki Olomuc FacMed 1985; 108(52): 29–38.Google Scholar
  219. CS219.
    Woo, W. S., E. B. Lee, K. H. Shin, S. S. Kang and H. J. Chi. A review of research on plants for fertility regulation in Korea. Korean J Pharmacol 1981; 12(3): 153–170.Google Scholar
  220. CS220.
    Dabby, V. Acute pancreatitis after marijuana smoking: Is there a relationship? JAMA 1985; 253(12): 1791.Google Scholar
  221. CS221.
    Mendelson, J. H., N. K. Mello and J. Ellingboe. Acute effects of marihuana smoking on prolactin levels in human females. J Pharmacol Exp Ther 1985; 232(1): 220–222.PubMedGoogle Scholar
  222. CS222.
    Manandhar, N. P. Ethnobotany of Jumla District, Nepal. Int J Crude Drug Res 1986; 24(2): 81–89.Google Scholar
  223. CS223.
    Montour, J. L., W. Dutz and L. S. Harris. Modification of radiation carcino-genesis by marihuana. Cancer 1981; 47(6): 1279–1285.PubMedGoogle Scholar
  224. CS224.
    O’Connell, M. E., G. A. Morrill, G. I. Fujimoto and A. B. Kostellow. Factors affecting the response of the female rat reproductive system to cannabinoids. Toxicol Appl Pharmacol 1987; 88(3): 411–417.PubMedGoogle Scholar
  225. CS225.
    Mendelson, J. H., P. Cristofaro, J. Ellingboe, R. Benedikt and N. K. Mello. Acute effects of marihuana on luteinizing hormone in menopausal women. Pharmacol Biochem Behav 1985; 23(5): 765–768.PubMedGoogle Scholar
  226. CS226.
    Evans, A. T., E. A. Formukong and F. J. Evans. Actions of cannabis constituents on enzymes of arachidonate metabolism: Anti-inflammatory potential. Biochem Pharmacol 1987; 36(12): 2035–2037.PubMedGoogle Scholar
  227. CS227.
    Rao, R. R. Ethnobotany of Meghalaya: Medicinal plants used by Khasi and Garo tribes. Econ Bot 1981; 35(1): 4–9.Google Scholar
  228. CS228.
    Sethi, N., D. Nath, R. K. Singh and R. K. Srivastava. Antifertility and teratogenic activity of Cannabis sativa in rats. Fitoterapia 1991; 62(1): 69–71.Google Scholar
  229. CS229.
    Renu. Fungitoxicity of leaf extracts of some higher plants against Rhizoctonia solani Kuehn. Nat Acad Sci Lett 1983; 6(8): 245–246.Google Scholar
  230. CS230.
    Yamamoto, I., T. Matsunaga, H. Kobayashi, K. Watanabe and H. Yoshimura. Analysis and pharmaco-toxicity of feruloyltyramine as a new constituent and P-coumaroyltyramine in Cannabis sativa L. Pharm Biochem Behavior 1991; 40(3): 465–469.Google Scholar
  231. CS231.
    Sauer, M. A., S. M. Rifka, R. L. Hawks, G. B. Cutler, Jr. and D. L. Loriaux. Marijuana: Interaction with the estrogen receptor. J Pharmacol Exp Ther 1983; 224(2): 404–407.PubMedGoogle Scholar
  232. CS232.
    Green, K., C. M. Symonds, D. R. Elijah, L. H. Zalkow, H. M. Deutsch, K. A. Bowman and T. R. Morgan. Water soluble marihuana-derived material: Pharmacological actions in rabbit and primate. Curr Eye Res 1981; 1(10): 599–608.PubMedGoogle Scholar
  233. CS233.
    Agnihotri, P. K., R. K. Singh and S. N. Sethi. Fototoxic effects of crude alcoholic Cannabis sativa extract in rats. Fitoterapia 1992; 63(6): 489–492.Google Scholar
  234. CS234.
    Lee, E. B., H. S. Yun and W. S. Woo. Plants and animals used for fertility regulation in Korea. Korean J Pharmacog 1977; 8: 81–87.Google Scholar
  235. CS235.
    Hunte, P., M. Safi, A. Macey and G. B. Kerr. Indigenous methods of voluntary fertility regulation in Afghanistan. Natl Demographic Fam Guid Surv Settled Pop Afghanistan 1975; 4: 1.Google Scholar
  236. CS236.
    Okey, A. B. and G. S. Truant. Cannabis demasculinizes rats but is not estrogenic. Life Sci 1976; 17: 1113.Google Scholar
  237. CS237.
    Nene, Y. L., P. N. Thapliyal and K. Kumar. Screening of some plant extracts for antifungal properties. Lab Dev J Sci Tech B 1968; 6(4): 226–228.Google Scholar
  238. CS238.
    Asprey, G. F. and P. Thornton. Medicinal plants of Jamaica. III. West Indian Med J 1955; 4: 69–82.PubMedGoogle Scholar
  239. CS239.
    Friedrich-Fiechtl, J. and G. Spiteller. New cannabinoids. I. Tetrahedron 1975; 31: 479–487.Google Scholar
  240. CS240.
    Kubena, R. K., H. Barry III, A. B. Selegman, M. Theiner and N. R. Farnsworth. Biological and chemical evaluation of a 43-year old sample of cannabis fluidextract. J Pharm Sci 1972; 61(1): 144–145.PubMedGoogle Scholar
  241. CS241.
    Gellert, M., I. Novak, M. Szell and K. Szendreil. Glycosidic Components of Cannabis sativa L. Undocument St/Soa/Ser. S/50 1974; 50: 8 pp.Google Scholar
  242. CS242.
    Segelman, A. B., F. P. Segelman, R. D. Sofia and A. E. Star. Some pharmacological effects of certain cannabinoid-free marijuana extracts. Lloydia 1974; 37(4): 645A.Google Scholar
  243. CS243.
    Vieira, J. E. V., G. S. G. Barros, M. C. Medeiros, F. J. A. Matos, M. P. Souza and M. J. Medeiros. Pharmacologic screening of plants from Northeast Brazil. II. Rev Brasil Farm 1968; 49:67–75.Google Scholar
  244. CS244.
    Dixit, V. P., V. N. Sharma and N. K. Lohiya. The effect of chronically administered cannabis extract on the testicular function of mice. Eur J Pharmacol 1974; 26: 111–114.PubMedGoogle Scholar
  245. CS245.
    Pinheiro de Sousa, M. and M. Z. Rouquayrol. Molluscicidal activity of plants from Northeast Brazil. Rev Bras Pesq Med Biol 1974; 7(4): 389–394.Google Scholar
  246. CS246.
    Nayar, S. L. Vegetable insecticides. Bull Natl Inst Sci India 1955; 4: 137–145.Google Scholar
  247. CS247.
    Anon. The Herbalist. Hammond Book Company, Hammond Indiana, 1931; 400 pp.Google Scholar
  248. CS248.
    Anon. Western Arabia and the Red Sea. Geographical Handbook Series B.R.527. Great Britain Naval Intelligence Division 1946: 590–602.Google Scholar
  249. CS249.
    Compton M. T., A. C. Furman, and N. J. Kaslow. Preliminary evidence of an association between childhood abuse and cannabis dependence among African American first-episode schizophrenia-spectrum disorder patients. Drug Alcohol Depend 2004; 76(3): 311–316.PubMedGoogle Scholar
  250. CS250.
    Pillay, S. S., J. Rogowska, G. Kanayama, et al. Neurophysiology of motor function following cannabis discontinuation in chronic cannabis smokers: a fMRI study. Drug Alcohol Depend 2004; 76(3): 261–271.PubMedGoogle Scholar
  251. CS251.
    Berman, J. S., C. Symonds, and R. Birch. Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. Pain 2004; 112(3): 299–306.PubMedGoogle Scholar
  252. CS252.
    Wilcox, H. C. and J. C. Anthony. The development of suicide ideation and attempts: an epidemiologic study of first graders followed into young adulthood. Drug Alcohol Depend 2004; 76(Suppl): S53–S67.PubMedGoogle Scholar
  253. CS253.
    Balerio, G. N., E. Aso, F. Berrendero, P. Murtra, and R. Maldonado. Delta9-tet-rahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice. Eur J Neurosci 2004; 20(10): 2737–2748.PubMedGoogle Scholar
  254. CS254.
    Fernandez-Ruiz, J., M. Gomez, M. Hernandez, R. de Miguel, and J. A. Ramos. Cannabinoids and gene expression during brain development. Neurotox Res 2004; 6(5): 389–401.PubMedGoogle Scholar
  255. CS255.
    Hungund, B. L. and B. S. Basavarajappa. Role of Endocannabinoids and Cannabinoid CB1 Receptors in Alcohol-Related Behaviors. Ann NY Acad Sci 2004; 1025: 515–527.PubMedGoogle Scholar
  256. CS256.
    Teichtahl, H., D. Wang, D. Cunning-ton, I. Kronborg, C. Goodman, A. Prodromidis, and O. Drummer. Cardiorespiratory function in stable methadone maintenance treatment (MMT) patients. Addict Biol 2004; 9(3–4): 247–253.PubMedGoogle Scholar
  257. CS257.
    Jockers-Scherubl, M. C., H. Danker-Hopfe, R. Mahlberg, et al. Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse. Neurosci Lett 2004; 371(1): 79–83.PubMedGoogle Scholar
  258. CS258.
    Allen, J. H., G. M. de Moore, R. Heddle, and J. C. Twartz. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut 2004; 53(11): 1566–1570.PubMedGoogle Scholar
  259. CS259.
    Carroll, C.B., P. G. Bain, L. Teare, et al. Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study. Neurology 2004; 63(7): 1245–1250.PubMedGoogle Scholar
  260. CS260.
    Lynskey, M. T., A. L. Glowinski, A. A. Todorov, et al. Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use. Arch Gen Psychiatry 2004; 61(10): 1026–1032.PubMedGoogle Scholar
  261. CS261.
    Te Poele, R., and J. Shamash, et al. Cannabis induced cytotoxicity in leukaemic cell lines: the role of the cannabinoid receptors and the MAPK pathway. Blood 2004 Sep 28 (Epub ahead of print).Google Scholar
  262. CS262.
    Venderova, K., E. Ruzicka, V. Vorisek, and P. Visnovsky. Survey on cannabis use in Parkinson’s disease: subjective improvement of motor symptoms. Mov Disord2004; 19(9): 1102–1106.Google Scholar
  263. CS263.
    Uribe Roca, M. C., F. Micheli, and R. Viotti. Cannabis sativa and dystonia secondary to Wilson’s disease. Mov Disord 2004 Aug 10 (Epub ahead of print).Google Scholar
  264. CS264.
    Stefanis, N. C., P. Delespaul, C. Henquet, C. Bakoula, C. N. Stefanis, and J. Van Os. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004; 99(10): 1333–1341.PubMedGoogle Scholar
  265. CS265.
    Kalant, H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28(5):849–863.PubMedGoogle Scholar
  266. CS266.
    Shukla, P. C. and U. B. Moore. Marijuana-induced transient global amnesia. South Med J 2004; 97(8): 782–784.PubMedGoogle Scholar
  267. CS267.
    Roy, B. and B. K. Dutta. In vitro lethal efficacy of leaf extract of Cannabis sativa Linn on the larvae of Chironomous samoensis Edward: an insect of public health concern. Indian J Exp Biol 2003; 41(11): 1338–1341.PubMedGoogle Scholar
  268. CS268.
    Wade. D. T., P. Makela, P. Robson, H. House, and C. Bateman. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult Scler 2004; 10(4): 434–441.PubMedGoogle Scholar
  269. CS269.
    Brady, C. M., R. Das Gupta, C. Dalton, O. J. Wiseman, K. J. Berkley, and C. J. Fowler. An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. Mult Scler 2004; 10(4): 425–433.PubMedGoogle Scholar
  270. CS270.
    Vaney, C., M. Heinzel-Gutenbrunner, P. Jobin, et al. Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study. Mult Scler 2004; 10(4): 417–424.PubMedGoogle Scholar
  271. CS271.
    Finsterer, J., P. Christian, and K. Wolfgang. Occipital stroke shortly after cannabis consumption. Clin Neurol Neurosurg 2004; 106(4): 305–308.PubMedGoogle Scholar
  272. CS272.
    Patel, S., B. F. Cravatt and C. J. Hillard. Synergistic Interactions between Cannabinoids and Environmental Stress in the Activation of the Central Amygdala. Neuropsychopharmacology 2004 Jul 28 (Epub ahead of print).Google Scholar
  273. CS273.
    Velasco, G., I. Galve-Roperh, C. Sanchez, C. Blazquez, and M. Guzman. Hypothesis: cannabinoid therapy for the treatment of gliomas? Neuropharmacology 2004; 47(3): 315–323.PubMedGoogle Scholar
  274. CS274.
    Burstein, S. H., M. Karst, U. Schneider, and R. B. Zurier. Ajulemic acid: A novel cannabinoid produces analgesia without a “high.” Life Sci 2004; 75(12): 1513–1522.PubMedGoogle Scholar
  275. CS275.
    Kogan, N. M., R. Rabinowitz, P. Levi, et al. Synthesis and antitumor activity of quinonoid derivatives of cannabinoids. J Med Chem 2004; 47(15): 3800–3806.PubMedGoogle Scholar
  276. CS276.
    Kelleher, L. M., C. Stough, A. A. Sergejew, and T. Rolfe. The effects of cannabis on information-processing speed. Addict Behav 2004; 29(6): 1213–1219.PubMedGoogle Scholar
  277. CS277.
    Verdoux, H. and M. Tournier. Cannabis use and risk of psychosis, an etiological link? Presse Med 2004; 33(8): 551–554.PubMedGoogle Scholar
  278. CS278.
    Whalley, B. J., J. D. Wilkinson, E. M. Williamson, and A. Constanti. A novel component of cannabis extract potentiates excitatory synaptic transmission in rat olfactory cortex in vitro. Neurosci Lett 2004; 365(1): 58–63.PubMedGoogle Scholar
  279. CS279.
    Kraft, B. and H. G. Kress. Cannabinoids and the immune system. Of men, mice and cells Schmerz 2004; 18(3): 203–210.PubMedGoogle Scholar
  280. CS280.
    Solinas, M., A. Zangen, N. Thiriet, and S. R. Goldberg. Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol. Eur J Neurosci. 2004; 19(12): 3183–3192.PubMedGoogle Scholar
  281. CS281.
    Kanayama, G., J. Rogowska, H. G. Pope, S. A. Gruber, and D. A. Yurgelun-Todd. Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology (Berl) 2004; 176(3–4): 239–247.Google Scholar
  282. CS282.
    Smith, A. M., P. A. Fried, M. J. Hogan, and I. Cameron. Effects of prenatal marijuana on response inhibition: an fMRI study of young adults. Neurotoxicol Teratol 2004; 26(4): 533–542.PubMedGoogle Scholar
  283. CS283.
    Goldschmidt, L., G. A. Richardson, M. D. Cornelius, and N. L. Day. Prenatal marijuana and alcohol exposure and academic achievement at age 10. Neurotoxicol Teratol 2004; 26(4): 521–532.PubMedGoogle Scholar
  284. CS284.
    Lozsadi, D. A., A. Forster, N. A. Fletcher. Cannabis-induced propriospinal myoclonus. Mov Disord 2004; 19(6): 708–709.PubMedGoogle Scholar
  285. CS285.
    Hernandez-Avila, C. A., B. J. Rounsaville, and H. R. Kranzler. Opioid-, cannabis-and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend 2004; 74(3): 265–272.PubMedGoogle Scholar
  286. CS286.
    Russo, E. B., A. Merzouki, J. M. Mesa, K. A. Frey, and P. J. Bach. Cannabis improves night vision: a case study of dark adaptometry and scotopic sensitivity in kif smokers of the Rif mountains of northern Morocco. J Ethnopharmacol 2004; 93(1): 99–104.PubMedGoogle Scholar
  287. CS287.
    D’souza, D. C., E. Perry, L. MacDougall, et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannab-inol in healthy individuals: implications for psychosis. Neuropsychopharmacology 2004; 29(8): 1558–1572.Google Scholar
  288. CS288.
    Russo, E. B. Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome, and other treatment-resistant conditions? Neuro Endocrinol Lett 2004; 25(1–2): 31–39.PubMedGoogle Scholar
  289. CS289.
    Furler, M. D., T. R. Einarson, M. Millson, S. Walmsley, and R. Bendayan. Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care STDS 2004; 18(4): 215–228.PubMedGoogle Scholar
  290. CS290.
    Nicholson, A. N., C. Turner, B. M. Stone, and P. J. Robson. Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol 2004; 24(3): 305–313.PubMedGoogle Scholar
  291. CS291.
    Rodriguez De Fonseca, F., M. A. Gorriti, A. Bilbao et al. Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson’s disease and schizophrenia. Neurotox Res 2001; 3(1): 23–35.PubMedGoogle Scholar
  292. CS292.
    Gadzicki, D., K. R. Muller-Vahl, D. Heller, et al. Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene. Am J Med Genet 2004; 127B(1): 97–103.Google Scholar
  293. CS293.
    Oliva, J. M., S. Ortiz, T. Palomo, and J. Manzanares. Spontaneous cannabinoid withdrawal produces a differential time-related responsiveness in cannabinoid CB1 receptor gene expression in the mouse brain. J Psychopharmacol 2004; 18(1): 59–65.PubMedGoogle Scholar
  294. CS294.
    Notcutt, W., M. Price, R. Miller, et al. Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 ‘N of 1’ studies. Anaesthesia 2004; 59(5): 440–452.PubMedGoogle Scholar
  295. CS295.
    Gomez, M., M. Hernandez, B. Johansson, R. de Miguel, J. A. Ramos, and J. Fernandez-Ruiz. Prenatal cannabinoid and gene expression for neural adhesion molecule L1 in the fetal rat brain. Brain Res Dev 2003; 147(1–2): 201–207.Google Scholar
  296. CS296.
    Amtmann, D., P. Weydt, K. L. Johnson, M. P. Jensen, and G. T. Carter. Survey of cannabis use in patients with amyotrophic lateral sclerosis. Am J Hosp Palliat Care 2004; 21(2): 95–104.PubMedGoogle Scholar
  297. CS297.
    Contassot, E., M. Tenan, V. Schnuriger, M. F. Pelte, and P. Y. Dietrich. Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1. Gynecol Oncol 2004; 93(1): 182–188.PubMedGoogle Scholar
  298. CS298.
    Iuvone, T., G. Esposito, R. Esposito, R. Santamaria, M. Di Rosa, and A. A. Izzo. Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC1 2 cells. J Neurochem 2004; 89(1): 134–141.PubMedGoogle Scholar
  299. CS299.
    Ng, R. S., D. A. Darko, and R. M. Hillson. Street drug use among young patients with Type 1 diabetes in the UK. Diabet Med 2004; 21(3): 295–296.PubMedGoogle Scholar
  300. CS300.
    Dannon, P. N., K. Lowengrub, R. Amiaz, L. Grunhaus, and M. Kotler. Comorbid cannabis use and panic disorder: short term and long term follow-up study. Hum Psychopharmacol 2004; 19(2): 97,101.Google Scholar
  301. CS301.
    Williams, L. J., A. Correa, and S. Rasmussen. Maternal lifestyle factors and risk for ventricular septal defects. Birth Defects Res Part A Clin Mol Teratol 2004; 70(2): 59–64.PubMedGoogle Scholar
  302. CS302.
    Laure, P., T. Lecerf, A. Friser, and C. Binsinger. Drugs, recreational drug use and attitudes towards doping of high school athletes. Int J Sports Med 2004; 25(2): 133–138.PubMedGoogle Scholar
  303. CS303.
    Costa, B., M. Colleoni, S. Conti, D. Parolaro, C. Franke, A. E. Trovato, and G. Giagnoni. Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw. Naunyn Schmiedebergs Arch Pharmacol 2004; 369(3): 294–299.PubMedGoogle Scholar
  304. CS304.
    Jockers-Scherubl, M. C., U. Matthies, H. Danker-Hopfe, U. E. Lang, R. Mahlberg, and R. Hellweg. Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients. J Psycho-pharmacol 2003; 17(4): 439–445.Google Scholar
  305. CS305.
    Venance, L., R. Maldonado, and O. Manzoni. Endocannabinoids in the central nervous system Med Sci (Paris) 2004; 20(1): 45–53.Google Scholar
  306. CS306.
    Stuyt, E. B. Hepatitis C in patients with co-occurring mental disorders and substance use disorders: is tobacco use a possible risk factor? Am J Addict 2004; 13(1): 46–52.PubMedGoogle Scholar
  307. CS307.
    Tsai, J. C., S. Tsai, and W. C. Chang. Effect of ethanol extracts of three Chinese medicinal plants with laxative properties on ion transport of the rat intestinal epithelia. Biol Pharm Bull 2004; 27(2): 162–165.PubMedGoogle Scholar
  308. CS308.
    Ducasse, E., J. Chevalier, D. Dasnoy, F. Speziale, P. Fiorani, and P. Puppinck. Popliteal artery entrapment associated with cannabis arteritis. Eur J Vasc Endovasc Surg 2004; 27(3): 327–332.PubMedGoogle Scholar
  309. CS309.
    Janczyk, P., C. W. Donaldson, and S. Gwaltney. Two hundred and thirteen cases of marijuana toxicoses in dogs. Vet Hum Toxicol 2004; 46(1): 19–21.PubMedGoogle Scholar
  310. CS310.
    Llewellyn, C. D., K. Linklater, J. Bell, N. W. Johnson, and S. Warnakulasuriya. An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol 2004; 40(3): 304–313.PubMedGoogle Scholar
  311. CS311.
    Westfall, R. E. Use of anti-emetic herbs in pregnancy: women’s choices, and the question of safety and efficacy. Complement Ther Nurs Midwifery 2004; 10(1): 30–36.PubMedGoogle Scholar
  312. CS312.
    Wilkinson, J. D., B. J. Whalley, D. Baker, et al. Medicinal cannabis: is delta9-tetrahydrocannabinol necessary for all its effects? J Pharm Pharmacol 2003; 55(12): 1687–1694.PubMedGoogle Scholar
  313. CS313.
    Grant, P. and P. A. Gandhi. A case of cannabis-induced pancreatitis. JOP 2004; 5(1): 41–43.PubMedGoogle Scholar
  314. CS314.
    Akerman, S., H. Kaube, and P. J. Goadsby. Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. J Pharmacol Exp Ther 2004; 309(1): 56–63.PubMedGoogle Scholar
  315. CS315.
    Prentiss, D., R. Power, G. Balmas, G. Tzuang, and D. M. Israelski. Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. J Acquir Immune Defic Syndr 2004; 35(1): 38–45.PubMedGoogle Scholar
  316. CS316.
    Park, B., J. M. McPartland, and M. Glass. Cannabis, cannabinoids and reproduction. Prostaglandins Leukot Essent Fatty Acids 2004; 70(2): 189–197.PubMedGoogle Scholar
  317. CS317.
    Singh, A. B. and P. Kumar. Aeroaller-gens in clinical practice of allergy in India. An overview. Ann Agric Environ Med 2003; 10(2): 131–136.PubMedGoogle Scholar
  318. CS318.
    Jones, S. and J. Howl. Cannabinoid receptor systems: therapeutic targets for tumour intervention. Expert Opin Ther Targets 2003; 7(6): 749–758.PubMedGoogle Scholar
  319. CS319.
    Chiriboga, C. A. Fetal alcohol and drug effects. Neurologist 2003; 9(6): 267–279.PubMedGoogle Scholar
  320. CS320.
    Luo, J., J. H. Yin, H. Z. Wu, and Q. Wei. Extract from Fructus cannabis activating calcineurin improved learning and memory in mice with chemical drug-induced dysmnesia. Acta Pharmacol Sin 2003; 24(11): 1137–1142.PubMedGoogle Scholar
  321. CS321.
    Degenhardt, L., W. Hall, and M. Lynskey. Exploring the association between cannabis use and depression. Addiction 2003; 98(11): 1493–1504.PubMedGoogle Scholar
  322. CS322.
    Zajicek, J., P. Fox, H. Sanders, et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet 2003; 362(9395): 1517–1526.PubMedGoogle Scholar
  323. CS323.
    Gaetani, S., V. Cuomo, and D. Piomelli. Anandamide hydrolysis: a new target for anti-anxiety drugs? Trends Mol Med 2003; 9(11): 474–478.PubMedGoogle Scholar
  324. CS324.
    McCambridge, J., J. Strang, S. Platts, and J. Witton. Cannabis use and the GP: brief motivational intervention increases clinical enquiry by GPs in a pilot study. Br J Gen Pract 2003; 53(493): 637–639.PubMedGoogle Scholar
  325. CS325.
    Koenen, K. C., M. J. Lyons, J. Goldberg et al. Co-twin control study of relationships among combat exposure, combat-related PTSD, and other mental disorders. J Trauma Stress 2003; 16(5): 433–438.PubMedGoogle Scholar
  326. CS326.
    Buggy, D. J., L. Toogood, S. Maric, P. Sharpe, D. G. Lambert, and D. L. Rowbotham. Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain. Pain 2003; 106(1–2): 169–172.PubMedGoogle Scholar
  327. CS327.
    Park, B., H. M. Gibbons, M. D. Mitchell, and M. Glass. Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta. Placenta 2003; 24(10): 990–995.PubMedGoogle Scholar
  328. CS328.
    Guzman, M. Cannabinoids: potential anticancer agents. Nat Rev Cancer 2003; 3(10): 745–755.PubMedGoogle Scholar
  329. CS329.
    Muller-Vahl, K. R. Cannabinoids reduce symptoms of Tourette’s syndrome. Expert Opin Pharmacother 2003; 4(10): 1717–1725.PubMedGoogle Scholar
  330. CS330.
    Naef, M., M. Curatolo, S. Petersen-Felix, L. Arendt-Nielsen, A. Zbinden, and R. Brenneisen. The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions. Pain 2003; 105(1–2): 79–88.PubMedGoogle Scholar
  331. CS331.
    Padley, J. R., Q. Li, P. M. Pilowsky, and A. K. Goodchild. Cannabinoid receptor activation in the rostral ventrolateral medulla oblongata evokes cardio-respiratory effects in anaesthetised rats. Br J Pharmacol 2003; 140(2): 384–394.PubMedGoogle Scholar
  332. CS332.
    Semple, D. M., F. Ramsden, and A. M. McIntosh. Reduced binocular depth inversion in regular cannabis users. Pharmacol Biochem Behav 2003; 75(4): 789–793.PubMedGoogle Scholar
  333. CS333.
    Sheweita, S. A. Narcotic drugs change the expression of cytochrome P450 2E1 and 2C6 and other activities of carcinogen-metabolizing enzymes in the liver of male mice. Toxicology 2003; 191(2–3): 133–142.PubMedGoogle Scholar
  334. CS334.
    Luo, J., J. H. Yin, and Q. Wei. The effect of calcineurin activator, extracted from Chinese herbal medicine, on memory and immunity in mice. Pharmacol Biochem Behav 2003; 75(4): 749–754.PubMedGoogle Scholar
  335. CS335.
    Clough, A. R., Z. Wang, R. S. Bailie, C. B. Burns, and B. J. Currie. Case-control study of the association between kava use and pneumonia in eastern Arnhem and Aboriginal communities (Northern Territory, Australia). Epidemiol Infect 2003; 131(1): 627–635.PubMedGoogle Scholar
  336. CS336.
    Groger, A., A. Aslani, T. Wolter, E. M. Noah, and N. Pallua. A rare case of cannabis arteritis. Vasa 2003; 32(2): 95–97.PubMedGoogle Scholar
  337. CS337.
    Grant, I., R. Gonzalez, C. L. Carey, L. Natarajan, and T. Wolfson. Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychol Soc 2003; 9(5): 679–689.PubMedGoogle Scholar
  338. CS338.
    Gilgun-Sherki, Y., E. Melamed, R. Mechoulam, and D. Offen. The CB1 cannabinoid receptor agonist, HU-210, reduces levodopa-induced rotations in 6-hydroxydopamine-lesioned rats. Pharmacol Toxicol 2003; 93(2): 66–70.PubMedGoogle Scholar
  339. CS339.
    Pryce, G., Z. Ahmed, D. L. Hankey, et al. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain 2003; 126(Pt. 10): 2191–2202.PubMedGoogle Scholar
  340. CS340.
    Mathew, R. J., W. H. Wilson, and R. Davis. Postural syncope after marijuana: a transcranial Doppler study of the hemodynamics. Pharmacol Biochem Behav 2003; 75(2): 309–318.PubMedGoogle Scholar
  341. CS341.
    Noland, J. S., L. T. Singer, S. K. Mehta, and D. M. Super. Prenatal cocaine/polydrug exposure and infant performance on an executive functioning task. Dev Neuropsychol 2003; 24(1): 499–517.PubMedGoogle Scholar
  342. CS342.
    Taylor, D. R. and W. Hall. Respiratory health effects of cannabis: position statement of the Thoracic Society of Australia and New Zealand. Intern Med J 2003; 33(7): 310–313.PubMedGoogle Scholar
  343. CS343.
    O’Leary, D. S., R. I. Block, B. M. Turner et al. Marijuana alters the human cerebellar clock. Neuroreport 2003; 14(8): 1145–1151.PubMedGoogle Scholar
  344. CS344.
    Fried, P. A., B. Watkinson, and R. Gray. Differential effects on cognitive functioning in 13-to 16-year-olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol 2003; 25(4): 427–436.PubMedGoogle Scholar
  345. CS345.
    Muller-Vahl, K. R., U. Schneider, H. Prevedel, et al. Delta 9-tetrahydrocan-nabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. J Clin Psychiatry 2003; 64(4): 459–465.PubMedGoogle Scholar
  346. CS346.
    Verrico, C. D., J. D. Jentsch, and R. H. Roth. Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats. Synapse 2003; 49(1): 61–66.PubMedGoogle Scholar
  347. CS347.
    Killestein, J., E. L. Hoogervorst, M. Reif, et al. Immunomodulatory effects of orally administered cannabinoids in multiple sclerosis. J Neuroimmunol 2003; 137(1–2): 140–143.PubMedGoogle Scholar
  348. CS348.
    Daniels, I. R. and G. T. Layer. How should gynaecomastia be managed? ANZ J Surg 2003; 73(4): 213–216.PubMedGoogle Scholar
  349. CS349.
    Cazalets, C., E. Laurat, B. Cador, et al. Grosbois. Cannabis arteritis: four new cases. Rev Med Interne 2003; 24(2): 127–130.PubMedGoogle Scholar
  350. CS350.
    Saso, L. Effects of drug abuse on sexual response. Ann Ist Super Sanita 2002; 38(3): 289–296.PubMedGoogle Scholar
  351. CS351.
    Ware, M. A., C. R. Doyle, R. Woods, M. E. Lynch, and A. J. Clark Cannabis use for chronic non-cancer pain: results of a prospective survey. Pain 2003; 102(1–2): 211–216.PubMedGoogle Scholar
  352. CS352.
    Cota, D., G. Marsicano, B. Lutz, et al. Endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord 2003; 27(3): 289–301.PubMedGoogle Scholar
  353. CS353.
    Croxford, J. L. Therapeutic potential of cannabinoids in CNS disease. CNS Drugs 2003; 17(3): 179–202.PubMedGoogle Scholar
  354. CS354.
    Wade, D. T., P. Robson, H. House, P. Makela, and J. Aram. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil 2003; 17(1): 21–29.PubMedGoogle Scholar
  355. CS355.
    Peters, F. T., H. H. Maurer, and P. Hellstern. Prevalence of illicit drug use in plasmapheresis donors. Vox Sang 2003; 84(2): 91–95.PubMedGoogle Scholar
  356. CS356.
    Muller-Vahl, K. R., H. Prevedel, K. Theloe, H. Kolbe, H. M. Emrich, and U. Schneider. Treatment of Tourette syndrome with delta-9-tetrahydrocan-nabinol (delta 9-THC): no influence on neuropsychological performance. Neuropsychopharmacology 2003; 28(2): 384–388.PubMedGoogle Scholar
  357. CS357.
    Ebrahim, S. H. and J. Gfroerer. Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol 2003; 101(2): 374–379.PubMedGoogle Scholar
  358. CS358.
    Zurier, R. B., R. G. Rossetti, S. H. Burstein, and B. Bidinger. Suppression of human monocyte interleukin-1beta production by ajulemic acid, a nonpsychoactive cannabinoid. Biochem Pharmacol 2003; 65(4): 649–655.PubMedGoogle Scholar
  359. CS359.
    Flach, A. J. Delta-9-tetrahydrocannab-inol (THC) in the treatment of end-stage open-angle glaucoma. Trans Am Ophthalmol Soc 2002; 100: 215–222; discussion 222–224.PubMedGoogle Scholar
  360. CS360.
    Sarafian, T. A., S. Kouyoumjian, F. Khoshaghideh, D. P. Tashkin, and M. D. Roth. Delta 9-tetrahydrocannab-inol disrupts mitochondrial function and cell energetics. Am J Physiol Lung Cell Mol Physiol 2003; 284(2): L298–L306PubMedGoogle Scholar
  361. CS361.
    Clermont-Gnamien, S., S. Atlani, N. Attal, F. Le Mercier, F. Guirimand, and L. Brasseur. The therapeutic use of D9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain. Presse Med 2002; 31(39 Pt. 1): 1840–1845.PubMedGoogle Scholar
  362. CS362.
    Jones, R. T. Cardiovascular system effects of marijuana. J Clin Pharmacol 2002; 42(11 Suppl): 58S–63S.PubMedGoogle Scholar
  363. CS363.
    Brown, T. T. and A. S. Dobs. Endocrine effects of marijuana. J Clin Pharmacol 2002; 42(11 Suppl): 90S–96S.PubMedGoogle Scholar
  364. CS364.
    Chowdhury, A. R. Effect of pharmacological agents on male reproduction. Adv Contracept Deliv Syst 1987; 3(4): 347–352.PubMedGoogle Scholar
  365. CS365.
    Pardo, G., V. Legua, J. Remohi, and F. Bonilla-Musoles. Review and update: marijuana and reproduction. Acta Ginecol (Madr) 1985; 42(7): 420–429.Google Scholar
  366. CS366.
    Williams, S. M., E. A. Mitchell, and B. J. Taylor. Are risk factors for sudden infant death syndrome different at night? Arch Dis Child 2002; 87(4): 274–278.PubMedGoogle Scholar
  367. CS367.
    Mulheran, M., P. Middleton, and J. A. Henry. The acute effects of tetrahydrocannabinol on auditory threshold and frequency resolution in human subjects. Hum Exp Toxicol 2002; 21(6): 289–292.PubMedGoogle Scholar
  368. CS368.
    Ware, M. A., A. Gamsa, J. Persson, and M. A. Fitzcharles. Cannabis for chronic pain: case series and implications for clinicians. Pain Res Manag 2002; 7(2): 95–99.PubMedGoogle Scholar
  369. CS369.
    James, J. S. Marijuana safety study completed: weight gain, no safety problems. AIDS Treat News 2000; (348): 3–4.PubMedGoogle Scholar
  370. CS370.
    Ciccocioppo, R., L. Antonelli, M. Biondini, M. Perfumi, P. Pompei, and M. Massi. Memory impairment following combined exposure to delta(9)-tetrahydrocannabinol and ethanol in rats. Eur J Pharmacol 2002; 449(3): 245–252.PubMedGoogle Scholar
  371. CS371.
    Taylor, D. R., D. M. Fergusson, B. J. Milne, et al. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction 2002; 97(8): 1055–1061.PubMedGoogle Scholar
  372. CS372.
    Stock, S. L., E. Goldberg, S. Corbett, and D. K. Katzman. Substance use in female adolescents with eating disorders. J Adolesc Health 2002; 31(2): 176–182.PubMedGoogle Scholar
  373. CS373.
    Sarafian, T. A., S. Kouyoumjian, D. Tashkin, and M. D. Roth. Synergistic cytotoxicity of Delta(9)-tetrahydrocannabinol and butylated hydroxyanisole. Toxicol Lett 2002; 133(2–3): 171–179.PubMedGoogle Scholar
  374. CS374.
    Pistis, M., A. L. Muntoni, G. Pillolla, and G. L. Gessa. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study. Eur J Neurosci 2002; 15(11): 1795–1802.PubMedGoogle Scholar
  375. CS375.
    Dhawan, K., S. Kumar, and A. Sharma. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction. J Pharm Pharmacol 2002; 54(6): 875–881.PubMedGoogle Scholar
  376. CS376.
    Darling, M. R., G. M. Learmonth, and T. M. Arendorf. Oral cytology in cannabis smokers. SADJ 2002; 57(4): 132–135.PubMedGoogle Scholar
  377. CS377.
    Brody, S. and R. Preut. Cannabis, tobacco, and caffeine use modify the blood pressure reactivity protection of ascorbic acid. Pharmacol Biochem Behav 2002; 72(4): 811–816.PubMedGoogle Scholar
  378. CS378.
    Brophy. S. and A. Calin. Definition of disease flare in ankylosing spondylitis: the patients’ perspective. J Rheumatol 2002; 29(5): 954–958.PubMedGoogle Scholar
  379. CS379.
    Sauvanier, M., J. Constans, S. Skopinski et al. Lower limb occlusive arteriopathy: retrospective analysis of 73 patients with onset before the age of 50 years. J Mal Vasc 2002; 27(2): 69–76.PubMedGoogle Scholar
  380. CS380.
    Boyce, S. H. and M. A. Quigley. Uvulitis and partial upper airway obstruction following cannabis inhalation. Emerg Med (Fremantle) 2002; 14(1): 106–108.Google Scholar
  381. CS381.
    Gouzoulis-Mayfrank, E., S. Becker, S. Pelz, F. Tuchtenhagen, and J. Daumann. Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis? Biol Psychiatry 2002; 51(9): 766–769.PubMedGoogle Scholar
  382. CS382.
    Parker, L. A., R. Mechoulam, and C. Schlievert. Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats. Neuroreport 2002; 13(5): 567–570.PubMedGoogle Scholar
  383. CS383.
    Niveau, G. Cannabis-related flashback, a medico-legal case. Encephale 2002; 28(1): 77–79.PubMedGoogle Scholar
  384. CS384.
    Muller-Vahl, K. R., U. Schneider, A. Koblenz, et al. Treatment of Tourette’s syndrome with Delta 9-tetrahydrocan-nabinol (THC): a randomized crossover trial. Pharmacopsychiatry 2002; 35(2): 57–61.PubMedGoogle Scholar
  385. CS385.
    Fried, P., B. Watkinson, D. James, and R. Gray. Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults. CMAJ 2002; 166(7): 887–891.PubMedGoogle Scholar
  386. CS386.
    Alvaro, L. C., I. Iriondo, and F. J. Villaverde. Sexual headache and stroke in a heavy cannabis smoker. Headache 2002; 42(3): 224–226.PubMedGoogle Scholar
  387. CS387.
    McLeod, A. L., C. J. McKenna, and D. B. Northridge. Myocardial infarction following the combined recreational use of Viagra and cannabis. Clin Cardiol 2002; 25(3): 133–134.PubMedGoogle Scholar
  388. CS388.
    Solowij, N., R. S. Stephens, R. A. Roffman et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 2002; 287(9): 1123–1131.PubMedGoogle Scholar
  389. CS389.
    Fergusson, D. M., L. J. Horwood, and K. Northstone. Maternal use of cannabis and pregnancy outcome. BJOG 2002; 109(1): 21–27.PubMedGoogle Scholar
  390. CS390.
    Fox, S. H., M. Kellett, A. P. Moore, A. R. Crossman, and J. M. Brotchie. Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia. Mov Disord 2002; 17(1): 145–149.PubMedGoogle Scholar
  391. CS391.
    Elsner, F., L. Radbruch, and R. Sabatowski. Tetrahydrocannabinol for treatment of chronic pain. Schmerz 2001; 15(3): 200–204.PubMedGoogle Scholar
  392. CS392.
    Bachs, L. and H. Morland. Acute cardiovascular fatalities following cannabis use. Forensic Sci Int 2001; 124(2–3): 200–203.PubMedGoogle Scholar
  393. CS393.
    Earleywine, M. Cannabis-induced Koro in Americans. Addiction 2001; 96(11): 1663–1666.PubMedGoogle Scholar
  394. CS394.
    Kopelman, M. D., L. J. Reed, P. Marsden, et al. Amnesic syndrome and severe ataxia following the recreational use of 3,4-methylene-dioxy-methamphetamine (MDMA, ‘ecstasy’) and other substances. Neurocase 2001; 7(5): 423–432.PubMedGoogle Scholar
  395. CS395.
    Bovasso, G. B. Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry 2001; 158(12): 2033–2037.PubMedGoogle Scholar
  396. CS396.
    Arnold, J. C., A. N. Topple, P. E. Mallet, G. E. Hunt, and I. S. McGregor. The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain. Brain Res 2001; 921(1–2): 240–255.PubMedGoogle Scholar
  397. CS397.
    Lundqvist, T., S. Jonsson, and S. Warkentin. Frontal lobe dysfunction in long-term cannabis users. Neuro-toxicol Teratol 2001; 23(5): 437–443.Google Scholar
  398. CS398.
    Launay, D., V. Queyrel, P. Y. Hatron, U. Michon-Pasturel, E. Hachulla, and B. Devulder. Digital necrosis in a patient with anorexia nervosa. Association of vasculopathy and radial artery injury Presse Med 2000; 29(34): 1850–1852.PubMedGoogle Scholar
  399. CS399.
    Voruganti, L. N., P. Slomka, P. Zabel, A. Mattar, and A. G. Awad. Cannabis induced dopamine release: an in-vivo SPECT study. Psychiatry Res 2001; 107(3): 173–177.PubMedGoogle Scholar
  400. CS400.
    Tramer, M. R., D. Carroll, F. A. Campbell, D. J. Reynolds, R. A. Moore, and H. J. McQuay. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 2001; 323(7303): 16–21.PubMedGoogle Scholar
  401. CS401.
    Dowe, G., M. F. Smilkle, C. Thesiger, and E. M. Williams. Bloodborne sexually transmitted infections in patients presenting for substance abuse treatment in Jamaica. Sex Transm Dis 2001; 28(5): 266–269.PubMedGoogle Scholar
  402. CS402.
    Fishwick, D., L. J. Allan, A. Wright, C. M. Barber, and A. D. Curran. Respiratory symptoms, lung function, and cell surface markers in a group of hemp fiber processors. Am J Ind Med 2001; 39(4): 419–425.PubMedGoogle Scholar
  403. CS403.
    Scragg, R. K., E. A. Mitchell, R. P. Ford, J. M. Thompson, B. J. Taylor, and A. W. Stewart. Maternal cannabis use in the sudden death syndrome. Acta Paediatr 2001; 90(1): 57–60.PubMedGoogle Scholar
  404. CS404.
    Flisher, A. J. and D. O. Chalton. Adolescent contraceptive non-use and covariation among risk behaviors. J Adolesc Health 2001; 28(3): 235–241.PubMedGoogle Scholar
  405. CS405.
    Taylor, D. R., R. Poulton, T. E. Moffitt, P. Ramankutty, and M. R. Sears. The respiratory effects of cannabis dependence in young adults. Addiction 2000; 95(11): 1669–1677.PubMedGoogle Scholar
  406. CS406.
    Disdier, P., B. Granel, J. Serratrice, et al. Cannabis arteritis revisited—ten new case reports. Angiology 2001; 52(1): 1–5.PubMedGoogle Scholar
  407. CS407.
    Kosior, D. A., K. J. Filipiak, P. Stolarz, and G. Opolski. Paroxysmal atrial fibrillation in a young female patient following marijuana intoxication—a case report of possible association. Med Sci Monit 2000; 6(2): 386–389.PubMedGoogle Scholar
  408. CS408.
    Mani, S. K., A. Mitchell, and B. W. O’Malley. Progesterone receptor and dopamine receptors are required in Delta 9-tetrahydrocannabinol modulation of sexual receptivity in female rats. Proc Natl Acad Sci USA 2001; 98(3): 1249–1254.PubMedGoogle Scholar
  409. CS409.
    Schneider, F., N. Abdoucheli-Baudot, M. Tassart, F. Boudghene, and P. Gouny. Cannabis and tobacco: cofactors favoring juvenile obliterative arteriopathy. J Mal Vasc 2000; 25(5): 388–389.PubMedGoogle Scholar
  410. CS410.
    Mackirdy, C. and D. Shepherd. Capgras syndrome: possibly more common among the Maori of New Zealand. Aust NZ J Psychiatry 2000; 34(5): 865–868.Google Scholar
  411. CS411.
    Stokes, J. R., R. Hartel, L. B. Ford, and T. B. Casale. Cannabis (hemp) positive skin tests and respiratory symptoms. Ann Allergy Asthma Immunol 2000; 85(3): 238–240.PubMedGoogle Scholar
  412. CS412.
    Hampson, A. J., M. Grimaldi, M. Lolic, D. Wink, R. Rosenthal, and J. Axelrod. Neuroprotective antioxidants from marijuana. Ann N Y Acad Sci 2000; 899: 274–282.PubMedGoogle Scholar
  413. CS413.
    Goldschmidt, L., N. L. Day, and G. A. Richardson. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol 2000; 22(3): 325–336.PubMedGoogle Scholar
  414. CS414.
    Leweke, F. M., U. Schneider, M. Radwan, E. Schmidt, and H. M. Emrich. Different effects of nabilone and cannabidiol on binocular depth inversion in Man. Pharmacol Biochem Behav 2000; 66(1): 175–181.PubMedGoogle Scholar
  415. CS415.
    Payne, H. C. Traumatic brain injury, depression and cannabis use—assessing their effects on a cognitive performance. Brain Inj 2000; 14(5): 479–489.PubMedGoogle Scholar
  416. CS416.
    McDonald, A., N. D. Duncan, and D. I. Mitchell. Alcohol, cannabis and cocaine usage in patients with trauma injuries. West Indian Med J 1999; 48(4): 200–202.PubMedGoogle Scholar
  417. CS417.
    Fried, P. A., B. Watkinson, and R. Gray. Growth from birth to early adolescence in offspring prenatally exposed to cigarettes and marijuana. Neurotoxicol Teratol 1999; 21(5): 513–525.PubMedGoogle Scholar
  418. CS418.
    Balle, J., M. J. Olofsson, and J. Hilden. Cannabis and pregnancy. Ugeskr Laeger 1999; 161(36): 5024–5028.PubMedGoogle Scholar
  419. CS419.
    Von Mandach, U., M. M. Rabner, J. Wisser, and A. Huch. LSD and cannabis abuse in early pregnancy with good perinatal outcome. Case report and review of the literature. Gynakol Geburtshilfliche Rundsch 1999; 39(3): 125–129.Google Scholar
  420. CS420.
    Zenor, B. N., G. D. Weesner, and P. V. Malven. Endocrine and other responses to acute administration of cannabinoid compounds to non-stressed male calves. Life Sci 1999; 65(2): 125–133.PubMedGoogle Scholar
  421. CS421.
    Okereke, U. N., B. E. Weber, and R. H. Israel. Spontaneous pneumomediastinum in an 18-year-old black Sudanese high school student. J Natl Med Assoc 1999; 91(6): 357–359.PubMedGoogle Scholar
  422. CS422.
    Sherwood, R. A., J. Keating, V. Kavvadia, A. Greenough, and T. J. Peters. Substance misuse in early pregnancy and relationship to fetal outcome. Eur J Pediatr 1999; 158(6): 488–492.PubMedGoogle Scholar
  423. CS423.
    Ameri, A. The effects of cannabinoids on the brain. Prog Neurobiol 1999; 58(4): 315–348.PubMedGoogle Scholar
  424. CS424.
    Coghlan, D., M. Milner, T. Clarke, et al. Neonatal abstinence syndrome. Ir Med J 1999; 92(1): 232–233, 236.PubMedGoogle Scholar
  425. CS425.
    Zimmer, A., A. M. Zimmer, A. G. Hohmann, M. Herkenham, and T. I. Bonner. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 1999; 96(10): 5780–5785.PubMedGoogle Scholar
  426. CS426.
    Lyketsos, C. G., E. Garrett, K. Y. Liang, and J. C. Anthony. Cannabis use and cognitive decline in persons under 65 years of age. Am J Epidemiol 1999; 149(9): 794–800.PubMedGoogle Scholar
  427. CS427.
    Masset, D., J. H. Bourdon, J. Arditti-Djiane, and J. Jouglard. Impact of delta-9-tetrahydrocannabinol and its metabolites on the immune system. Acta Clin Belg Suppl 1999; 1: 39–43.PubMedGoogle Scholar
  428. CS428.
    Ehrenreich, H., T. Rinn, H. J. Kunert, et al. Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology (Berl) 1999; 142(3): 295–301.Google Scholar
  429. CS429.
    Leech, S. L., G. A. Richardson, L. Goldschmidt, and N. L. Day. Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds. Neurotoxicol Teratol 1999; 21(2): 109–118.PubMedGoogle Scholar
  430. CS430.
    Disdier, P., L. Swiader, J. Jouglard, et al. Cannabis-induced arteritis vs. Buerger disease. Nosologic discussion apropos of two new cases. Presse Med 1999; 28(2): 71–74.PubMedGoogle Scholar
  431. CS431.
    Gorriti, M. A., F. Rodriguez de Fonseca, M. Navarro, and T. Palomo. Chronic (-)-delta9-tetrahydrocannab-inol treatment induces sensitization to the psychomotor effects of amphetamine in rats. Eur J Pharmacol 1999; 365(2–3): 133–142.PubMedGoogle Scholar
  432. CS432.
    Ongradi, J., S. Specter, A. Horvath, and H. Friedman. Additive effect of marihuana and retrovirus in the anergy of natural killer cells in mice. Orv Hetil 1999; 140(2): 81–84.PubMedGoogle Scholar
  433. CS433.
    Eames, S. L., J. Westermeyer, and R. D. Crosby. Substance use and abuse among patients with comorbid dysthymia and substance disorder. Am J Drug Alcohol Abuse 1998; 24(4): 541–550.PubMedGoogle Scholar
  434. CS434.
    Jentsch, J. D., C. D. Verrico, D. Le, and R. H. Roth. Repeated exposure to delta 9-tetrahydrocannabinol reduces pre-frontal cortical dopamine metabolism in the rat. Neurosci Lett 1998; 246(3): 169–172.PubMedGoogle Scholar
  435. CS435.
    Matsunaga, T., K. Watanabe, H. Yoshimura, and I. Yamamoto. Quantitative analysis and pharmaco-toxicity of cannabinoids in commercially available cannabis seeds. Yakugaku Zasshi 1998; 118(9): 408–414.PubMedGoogle Scholar
  436. CS436.
    Rubio, P., F. Rodriguez de Fonseca, J. L. Martin-Calderon, et al. Maternal exposure to low doses of delta9-tetrahydrocannabinol facilitates morphine-induced place conditioning in adult male offspring. Pharmacol Biochem Behav 1998; 61(3): 229–238.PubMedGoogle Scholar
  437. CS437.
    English, D. R., G. K. Hulse, E. Milne, C. D. Holman, and C. I. Bower. Maternal cannabis use and birth weight: a meta-analysis. Addiction 1997; 92(11): 1553–1560.PubMedGoogle Scholar
  438. CS438.
    Block, R. I., W. J. Erwin, R. Farinpour, and K. Braverman. Sedative, stimulant, and other subjective effects of marijuana: relationships to smoking techniques. Pharmacol Biochem Behav 1998; 59(2): 405–412.PubMedGoogle Scholar
  439. CS439.
    Daisley, H., A. Jones-Le Cointe, G. Hutchinson, and V. Simmons. Fatal cardiac toxicity temporally related to poly-drug abuse. Vet Hum Toxicol 1998; 40(1): 21–22.PubMedGoogle Scholar
  440. CS440.
    Wang, M. Q., C. B. Collins, R. J. DiClemente, G. Wingood, and C. L. Kohler. Depressive symptoms as correlates of polydrug use for blacks in a high-risk community. South Med J 1997; 90(11): 1123–1128.PubMedGoogle Scholar
  441. CS441.
    Westermeyer, J., S. Kopka, and S. Nugent. Course and severity of substance abuse among patients with comorbid major depression. Am J Addict 1997; 6(4): 284–292.PubMedGoogle Scholar
  442. CS442.
    Schlicker, E., J. Timm, J. Zentner, and M. Gothert. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn Schmiedebergs Arch Pharmacol 1997; 356(5): 583–589.PubMedGoogle Scholar
  443. CS443.
    Middleman, A. B., L. M. Robertson, R. H. DuRant, V. Chiou, and S. J. Emans. Use of hormonal methods of birth control among sexually active adolescent girls. J Pediatr Adolesc Gynecol 1997; 10(4): 193–198.PubMedGoogle Scholar
  444. CS444.
    Heishman, S. J., K. Arasteh, and M. L. Stitzer. Comparative effects of alcohol and marijuana on mood, memory, and performance. Pharmacol Biochem Behav 1997; 58(1): 93–101.PubMedGoogle Scholar
  445. CS445.
    Ostrea, E. M. Jr., A. R. Ostrea, and P. M. Simpson. Mortality within the first 2 years in infants exposed to cocaine, opiate, or cannabinoid during gestation. Pediatrics 1997; 100(1): 79–83.PubMedGoogle Scholar
  446. CS446.
    Durst, R. and P. Rebaudengo-Rosca. Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult. Harefuah 1997; 132(9): 618–622,680.PubMedGoogle Scholar
  447. CS447.
    Holdcroft, A., M. Smith, A. Jacklin, et al. Pain relief with oral cannabinoids in familial Mediterranean fever. Anaesthesia 1997; 52(5): 483–486.PubMedGoogle Scholar
  448. CS448.
    Elwan, O., A. A. Hassan, M. Abdel Naseer et al. Brain aging in a sample of normal Egyptians cognition, education, addiction and smoking. J Neurol Sci 1997; 148(1): 79–86.PubMedGoogle Scholar
  449. CS449.
    Mirochnick, M., J. Meyer, D. A. Frank, H. Cabral, E. Z. Tronick, and B. Zuckerman. Elevated plasma norepinephrine after in utero exposure to cocaine and marijuana. Pediatrics 1997; 99(4): 555–559.PubMedGoogle Scholar
  450. CS450.
    Meier, H. and H. J. Vonesch. Cannabis poisoning after eating salad. Schweiz Med Wochenschr 1997; 127(6): 214–218.PubMedGoogle Scholar
  451. CS451.
    Sanudo-Pena, M. C., K. Tsou, E. R. Delay, A. G. Hohman, M. Force, and J. M. Walker. Endogenous cannabinoids as an aversive or counter-rewarding system in the rat. Neurosci Lett 1997; 223(2): 125–128.PubMedGoogle Scholar
  452. CS452.
    Ruh, M. F., J. A. Taylor, A. C. Howlett, and W. V. Welshons. Failure of cannabinoid compounds to stimulate estrogen receptors. Biochem Pharmacol 1997; 53(1): 35–41.PubMedGoogle Scholar
  453. CS453.
    Pope, H. G. Jr., A. Jacobs, J. P. Mialet, D. Yurgelun-Todd, and S. Gruber. Evidence for a sex-specific residual effect of cannabis on visuospatial memory. Psychother Psychosom 1997; 66(4): 179–184.PubMedGoogle Scholar
  454. CS454.
    Lawson, T. M. and A. Rees. Stroke and transient ischaemic attacks in association with substance abuse in a young man. Postgrad Med J 1996; 72(853): 692–693.PubMedGoogle Scholar
  455. CS455.
    Mallat, A., J. Roberson, and J. G. Brock-Utne. Preoperative marijuana inhalation—an airway concern. Can J Anaesth 1996; 43(7): 691–693.PubMedGoogle Scholar
  456. CS456.
    Napiorkowski, B., B. M. Lester, M. C. Freier, et al. Effects of in utero substance exposure on infant neurobehavior. Pediatrics 1996; 98(1): 71–75.PubMedGoogle Scholar
  457. CS457.
    Williams, J. H., N. A. Wellman, and J. N. Rawlins. Cannabis use correlates with schizotypy in healthy people. Addiction 1996; 91(6): 869–877.PubMedGoogle Scholar
  458. CS458.
    Boros, C. A, D. W. Parsons, G. D. Zoanetti, D. Ketteridge, and D. Kennedy. Cannabis cookies: a cause of coma. J Paediatr Child Health 1996; 32(2): 194–195.PubMedGoogle Scholar
  459. CS459.
    Navarro, M., R. de Miguel, F. Rodriguez de Fonseca, J. A. Ramos, and J. J. Fernandez-Ruiz. Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats. Behav Brain Res 1996; 75(1–2): 91–98.PubMedGoogle Scholar
  460. CS460.
    Richter, B., N. Marangos, A. Jeron, and S. Irscheid. 3 different malignancies of the aerodigestive tract after chronic abuse of cannabis products. HNO 1995; 43(12): 728–731.PubMedGoogle Scholar
  461. CS461.
    Wiley, J. L., J. W. Huffman, R. L. Balster, and B. R. Martin. Pharmacological specificity of the discriminative stimulus effects of delta 9-tet-rahydrocannabinol in rhesus monkeys. Drug Alcohol Depend 1995; 40(1): 81–86.PubMedGoogle Scholar
  462. CS462.
    Navarro, M., P. Rubio, and F. R. de Fonseca. Behavioural consequences of maternal exposure to natural cannabinoids in rats. Psychopharmacology (Berl) 1995; 122(1): 1–14.Google Scholar
  463. CS463.
    Romero, J., L. Garcia, J. J. Fernandez-Ruiz, M. Cebeira, and J. A. Ramos. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydro-cannabinol. Pharmacol Biochem Behav 1995; 51(4): 731–737.PubMedGoogle Scholar
  464. CS464.
    Souilhac, J., M. Poncelet, M. Rinaldi-Carmona, G. Le Fur, and P. Soubrie. Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice. Pharmacol Biochem Behav 1995; 51(1): 3–7.PubMedGoogle Scholar
  465. CS465.
    Shiono, P. H., M. A. Klebanoff, R. P. Nugent, et al. The impact of cocaine and marijuana use on low birth weight and preterm birth: a multicenter study. Am J Obstet Gynecol 1995; 172(1 Pt. 1): 19–27.PubMedGoogle Scholar
  466. CS466.
    Solowij, N., B. F. Grenyer, G. Chesher, and J. Lewis. Biopsychosocial changes associated with cessation of cannabis use: a single case study of acute and chronic cognitive effects, withdrawal and treatment. Life Sci 1995; 56(23–24): 2127–2134.PubMedGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2005

Personalised recommendations